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PREFACE
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1989, during the period of her employment as a Research 
Fellow in the Department of Academic Psychiatry, Royal Free 
Hospital School of Medicine, London.
Professor Anthony Mann acted as advisor for the study. The 
subject for thesis was the responsibility of the author, who 
co-ordinated the entire study and conducted assessments 
personally. The screening interviews of the elderly 
population required the assistance of a team of interviewers. 
The author screened about half of the population herself. 
She carried out Phase II and III interviews, comprising 
G.M.S.(A), physical examination, biochemical screening and 
informant interviews personally. The psychometric testing was 
carried out by Ms Karen Sax, a Research Assistant. Computer 
analysis of data took place at the Royal Free Hospital by Mr 
Robert Blizard, in discussion with the author.
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SUMMARY
Estimates of the prevalence rate of dementia in those aged 
over 65 and living in the community vary widely, from 0.5% 
to 6.3% for mild dementia, and from 1% to 7.4% for moderate 
or severe dementia. These figures have usually been obtained 
by screening and refer to non-specific dementia syndromes. 
Few studies have gone further to provide a detailed 
diagnostic breakdown on this cross-sectional detail, or 
followed patients up to obtain longditudinal data. Those 
that have provided further information have not provided full 
diagnostic profiles of unselected samples, leading to the 
likelihood of bias in the results.
Accurate results from community settings are crucial for the 
purposes of both services planning and to increase the 
knowledge of, and therefore improve management of the 
dementias. These studies by detecting and diagnosing early 
dementias, and following cases longditudinally will add to 
the knowledge of the natural history of dementia, leading to 
more accurate prognostic data. More accurate samples will 
also enable clearer evidence of genetic and environmental 
risk factors to be obtained. Prevention of dementia may 
ultimately be feasible when risk factors are known. Finally 
the best hope for effective pharmacological therapies lies 
in early dementia when there is less cell death.
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This study concerns the elderly residents of an electoral 
ward, the Gospel Oak Ward, in the London Borough of Camden. 
A list was completed of the pensioners living in this area. 
The pensioners were then screened for dementia using two 
scales, a screening scale and a diagnostic scale, from a 
semi-structured instrument, the Short CARE, to determine the 
prevalence rate for dementia.
Subjects who scored above the cutpoint on either of the two 
scales were then assessed in detail. If re-interview was not 
possible, for example because of death, other sources of 
information were utilized. This further assessment was for 
the purpose of a diagnostic subclassification of the 
dementias. This enabled precise prevalence rates of the 
different dementias to be determined, reversible dementias 
to be detected, and finally assessments to be made of the use 
of the various instruments in clinical practice.
The final phase of the study was an eighteen month follow up. 
The outcome was investigated in terms of mortality and change 
in morbidity.
It was found that the way to obtain an accurate list of 
elderly residents was by visiting individual residences. 
This accurate sample differed from a list obtained from
12
service providers by 56%. 87% of the sample were
interviewed. 56 (7.9%) crossed the cutpoint on the screening 
scale and 35 (4.7%) on the diagnostic scale (a total of 60). 
Prevalence of dementia on the diagnostic scale was 4.7% and 
rose with age.
48 (80%) of the study were assessed in detail, reinterviewed 
and 22 (46%) were diagnosed as having probable Alzheimer's 
Disease. One had multi-infarct dementia, five had mixed 
dementia, five had secondary dementia, ten had a dementia 
which could not be further classified and five were not 
demented. No subject had a reversible condition. The 
prevalence rate for clinical dementia was 6.1% and for 
Alzheimer disease 3.1%.
Eighteen months later 30 (79%) of those available were re­
interviewed. 10 (23%) had died, those who had been screened 
positives but not diagnosed clinically as demented remained 
not demented. Of the other survivors, 14 (54%) had
deteriorated, 4 (15%) of whom had been institutionalised;
6 (22%) were stable and 6 (22%) had improved. There was 
little difference in the outcomes on the different scales or 
different diagnoses, although those who were 'cases' on the 
dementia diagnostic scale were less likely to improve. 
Clinical diagnosis was a better predictor of deterioration 
than any of the instruments used.
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This study confirms that dementia increases in prevalence in 
older age groups. The elderly suffering from dementia in the 
community were different in diagnostic composition to 
hospital samples which have been reported, therefore 
extrapolation from hospital samples can result in a distorted 
picture. There were excess deaths when compared to an age 
matched population. Many cases of dementia did not 
deteriorate over eighteen months. Therefore maximising 
patients' health in early dementia in the community, may be 
helpful in preventing deterioration.
14
CHAPTER 1
INTRODUCTION
15
1.1 THE AGEING POPULATION
"Methuselah lived a hundred eighty and seven years and 
begot Lamech. And Methuselah lived after he begot Lamech 
seven hundred eighty and two years, and begot sons and 
daughters. And all the days of Methuselah were nine 
hundred sixty and nine years, and he died" (Genesis).
Methuselah, and perhaps other individuals through the 
ages, had long lives; but for the majority as recently as 
the 18th century, life expectancy was 25 to 35 years of 
age and survival beyond 50 was infrequent (Midwinter, 
1989). Even now in the late 20th century, life expectancy 
in some of the poorer nations is in a similar range.
This is illustrated in a world survey from the Centre for 
the Policy on Ageing, where the shortest life expectancy 
quoted (for those born in 1985), was in Sierra Leone, 
where men could expect to live till the age of 32.5 and 
women till 35.5 (Crosby et al. 1989). Similarly, in other 
nations (for example Gambia and Afghanistan) life 
expectancy is less than forty years. Some countries (like 
Taiwan, St Lucia and Grenada), are unable to quote any 
life expectancy figures, but have a similar or lower 
percentage of over 65s in their total population than 
Sierra Leone and Gambia. Therefore life expectancy in 
these countries is probably at least as low. However, even 
in these poorer nations the population is now ageing and
16
longevity is expected to increase by around 16 years for 
both men and women by 2025.
In contrast, in the richer nations, life expectancy has 
increased enormously in this century so that by 1985, the 
highest life expectancy for men was 74.3 years (in Japan), 
and for women 79.7 years (in both Japan and Switzerland). 
In the United Kingdom during this century, annual death 
rates have fallen from over 30 to 10 per 1,000 so that 
life expectancy for men has extended from 48.5 to 71.6 
years and for women from 51.4 to 77.6 years (Warnes, 
1989). This increased longevity, along with falling birth 
rates, has caused major changes in the age composition of 
the UK population. Further changes are now predicted in 
the numbers of very old people, that is those over 85 
years of age. By 1996 they will number 1.9% of the 
population, a 50% increase in 10 years comprising 
approximately 400,000 people who will be mainly female, 
widowed and living alone. (OPCS 1987).
As the population comes to contain more very old people, 
the numbers of those suffering from dementia rises, 
because the prevalence of dementia increases with age, 
doubling with every 5.1 years increase in age after 65 
years (Jorm et al. 1987). This problem resulting from our 
ageing population has been called the silent epidemic 
(Beck et al 1982), and has led to greatly increased 
research interest in dementia.
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1.2 THE DEFINITION OF THE ELDERLY
The definition of elderly is inevitably arbitrary and may 
change as the expectation of lifespan and health change. 
The concept of elderly may be statistical, biological or 
social. In statistical terms, for example, the oldest 5% 
of the population may be regarded as elderly. On this 
basis, in some countries old age might therefore begin in 
the mid-forties, while in 1986 in England it would not 
begin till after 75 years old (OPCS 1987). In contrast, 
biological old age might be defined as when deteriorating 
health leads to a defined level of disability, in a person 
who was not congenitally handicapped. In these terms old 
age would not therefore be chronological, although it 
would be more common in older individuals. Finally, old 
age can also be regarded as a social phenomenon, that is, 
when a particular society defines old age. For example, 
in the UK, 65 is the current age of male retirement and 
the age at which the patient receives the label 
"geriatric" in the health services.
Any definitions of the elderly will be culturally 
determined and vary according to place and time. 
Nevertheless, whichever social definition is used,it is 
chronological age of people in the population that seems 
to affect the prevalence rate of dementia. Therefore, it 
is important to know what is meant when the word elderly
18
is used. In this thesis the word 'elderly7 will refer to 
those of 65 and over, unless otherwise specified.
1.3 NEW INITIATIVES IN RESEARCH ON DEMENTIA
The consequences of dementia syndrome, are the 
disintegration of the intellect, personality, dignity and 
independence of the sufferer. This loss of independence 
means that the 'epidemic' affects the society as a whole, 
as help is required from both informal carers, and formal 
care, in the form of both medical and social services at 
home. As dementia usually follows a deteriorating course, 
in time it becomes impossible for informal carers to 
provide fully for the needs of the dementia sufferer and 
twenty-four hour care is needed in some form of 
residential care. Some two thirds of residents in social 
services facilities are demented (Mann et al 1984). Some 
become too difficult for these institutions, so that the 
health services, which up until that time has been in a 
supporting role are required to take over full care in a 
long stay facility. Therefore the implications of
dementia for health and social policy is enormous.
As the numbers of people with dementia is increasing, and 
the disease has wide personal and socio-economic 
implications, it is essential to obtain accurate 
epidemiological data on the prevalence rate of dementia
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and its distribution. Knowledge of the numbers of such 
cases provides useful data for management, and service 
needs. Dementia is a clinical diagnosis made on history 
and symptoms rather than upon underlying pathology or 
known aetiology. However, further diagnostic detail of 
the dementias is necessary, both for more accurate service 
planning and as a basis for further progress in 
investigating and managing this group of disorders.
To date most epidemiological research on the prevalence 
rate and diagnostic composition of the dementia syndrome 
has been carried out on unrepresentative samples. There 
is no report, in an unselected community sample, of a 
methodologically satisfactory study of the prevalence rate 
and complete diagnostic profile of those screened as 
suffering from dementia. The setting up of a register of 
all the elderly in a North London electoral area provided 
an opportunity to do this in three phases. In phase one, 
this sample has been screened to find population 
prevalence rates of dementia and depression, any other 
handicaps and of current service usage. Then a second 
phase investigation enabled a diagnostic profile of the 
dementias discovered in the sample, to be determined. 
Finally, in phase three an eighteen month follow-up of 
those subjects seen in phase two has been carried out, to 
determine the natural history of these dementias and to 
test the predictive value of the initial diagnostic 
subclassifications. The study is original and the author
20
the principal investigator and it forms the basis for this 
thesis.
21
CHAPTER 2 
WHAT IS DEMENTIA?
22
2.1. THE EXPERIENCE OF DEMENTIA
11 You have to begin to lose your memory, if only in bits 
and pieces to realise that memory is what makes our lives.
Life without memory is no life at all...... Our memory is
our coherence, our reason, our feeling, even our reaction. 
Without it we are nothing... (I can only wait for the final 
amnesia, the one that can erase an entire life as it did 
my mother's)"(Bunuel 1985).
This quote describes the experience of memory loss and 
its significance to the sufferer. In general most people 
with dementia lack this insight. This makes the mechanics 
of our task as doctors, to recognise and diagnose 
dementia, make services available and help advance 
knowledge of dementia; different from that in most 
illnesses, as the patient often does not recognise that 
there is a problem. The recognition of dementia and the 
difficulties in so doing are discussed in the rest of this 
chapter.
2.2. THE DEFINITION OF DEMENTIA
Dementia is a clinical term describing a symptom complex 
with many different aetiologies and pathologies. A 
consensus multidisciplinary conference in the United 
States of America defined dementia as "a clinical state
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with many different causes, characterised by a decline 
from a previously attained intellectual level... Although 
long lasting some varieties of dementia may be arrested or 
reversed...Some criteria for dementia require deficits in 
one or more components of intellectual function other 
than memory. Some require that the deficit be global.
....Dementia is a very variable state . It may be 
progressive ,as in the degenerative diseases or static ,as 
in a post brain injury state.
....Dementia is distinguished from mental retardation. 
Many different disease states are capable of producing 
dementia.... They may be found in all the classic 
categories of disease : intoxicant, infectious, metabolic, 
nutritional, vascular, neoplastic, genetic and traumatic." 
(Office of the Medical Application of Research 1987). In 
addition, there is the category degenerative dementia, 
which includes Alzheimer's Disease, the most common cause 
of dementia.
Four commonly used criteria for dementia are:- 1) the 
Diagnostic and statistical Manual-III-R (DSM-III-R) 2) 
the International Classification of Disease 9 (ICD9) 3) 
pervasive dementia used in the semi-structured assessment 
instrument short CARE (cf chapter 6 section 5). and 4) the 
GMS/Agecat criteria (cf chapter 6 section 5).
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1. D.S.M.IIIR
A) Demonstrable evidence of impairment in short and long 
term memory.
B) At least one of:
1) impairment in abstract thinking.
2) impaired judgement.
3) other disturbance of higher cortical function.
C) The disturbance of A and B significantly interferes 
with work or usual social activities or
relationships with others.
D) Not occurring exclusively during the course of
delirium.
E) Either:
1) evidence of a specific organic factor
etiologicaly related to the disturbance, 
or
2) disturbance cannot be accounted for by any 
nonorganic mental disorder eg major depression,
accounting for cognitive impairment.
2. I CD 9 refers to the dementia syndrome as "organic 
psychotic conditions". They are "syndromes in which there 
is impairment of orientation, memory, comprehension,
25
calculation, learning capacity and judgement.... of a 
chronic or progressive nature, which if untreated are 
usually irreversible and terminal".
3. Pervasive dementia is an operational diagnoses of 
cognitive impairment made from criteria comprised of 
ratings of the ShortCARE. They identify cases where there 
is a probable need for clinical investigation or 
intervention (Gurland et al 1984).
4. Finally the Agecat system defines a 'syndrome case' as 
a collection of symptoms which a psychiatrist would 
recognize as a characteristic and abnormal mental state 
for which intervention was appropriate, if available 
(Copeland et al 1986).
These definitions indicate the scope of the diagnoses of 
dementia, and attendant difficulties in reliable use of 
those diagnostic categories which will be discussed more 
fully in the next section.
2.3 PROBLEMS IN THE DIAGNOSIS OF DEMENTIA
The difficulties in the diagnosis of dementia fall into 
five main categories.
First the diagnosis is characterised by a decline from
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previous intellectual levels. This means that some 
individuals suffering from early dementia could still be 
functioning at a higher level than others who have no 
cognitive impairment. Conversely others with congenital 
learning difficulties may be impaired but have not 
declined. Alternatively, decline may occur in those 
already impaired, as for example is common in Down's 
Syndrome, so that mental handicap and dementia may co­
exist. In a clinical assessment, the history from an 
informant, together with a detailed psychometric tests, 
can usually overcome such diagnostic difficulties. 
However a community survey requires that large numbers of 
people be screened by an acceptable, economic and 
therefore rapid method. This can mean that some people 
will be wrongly classified.
Second, most dementia occurs in elderly people. With age 
there is a decrease in ability to learn new material and 
a slowing down in cognitive processes, which are countered 
by the use of stored knowledge and experience. It is 
therefore essential that testing for dementia does not 
emphasise the former abilities disproportionately or 
normal old people will be included, ie that testing is 
standardised for the appropriate age group . If this is 
not done then misclassification will occur, especially 
among the very elderly.
Third, other pathologies such as acute confusional state
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or depression may mimic dementia, as well as making 
existing cognitive impairment more marked. A mental 
state, physical examination and history are therefore 
necessary for diagnostic accuracy, which is difficult in 
community samples. This is especially the case in very 
early dementia, where cognition is impaired but function 
is intact, and which are likely to be missed without 
longitudinal studies (Morris & Fulling, 1988).
Fourth, cultural differences mean that an instrument which 
is standardised for one population may be inappropriate in 
another, because of differences in education and 
experience.
Finally, there are many different criteria for identifying 
dementia. The four most common ones are discussed above. 
Use of different criteria may classify individuals into 
different categories. For example I CD-9 defines dementia 
as chronic, progressive and generally irreversible, none 
of which criteria are in DSM-III-R.
These difficulties are all brought together when the 
detection of early dementia in a community population is 
attempted - yet such detection is important.
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2.4. THE NEED FOR ACCURATE ASCERTAINMENT OF EARLY
DEMENTIA
There is general agreement that accurate ascertainment of 
early dementia is needed. The reasons for this 
requirement have been discussed by Mowry & Burvill (1988) 
and Henderson & Huppert (1984), who regard early detection 
as a compelling priority, as early accurate diagnosis of 
dementia is useful for both management and research 
purposes. The reasons for this are described in more 
detail below.
Currently, however the criteria for accurate early 
diagnosis of dementia have not been universally agreed. 
Jorm et al (1987) in their review of the literature of the 
prevalence rates of mild dementia, report results varying 
from 0.5% - 16.3% of those over 65 years. The corollary 
of a high rate of mild dementia, was a lower rate of 
moderate and severe dementia implying that some of the 
variance was due to different cut points in the spectrum 
of mild to severe. Mowry & Burvill (1988) report 
prevalence rates of between 3 and 64% of mild dementia, in 
a random sample of non-institutionalised people aged over 
70. The rate depended on the instrument used. They 
therefore emphasise the importance of longitudinal 
studies, to validate the diagnosis of mild dementia.
In the area of management, early diagnosis may mean that
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dementia can be arrested at an earlier stage, or increase 
the possibility of reversal, for example when an operable 
space occupying lesion is found. Alternatively, as in the 
diagnosis of depressive pseudodementia, treatment may 
shorten the course of the illness. In most dementias, at 
present, reversal and curative treatment are not 
available. Nonetheless, early detection of dementia can 
help in other fields. Firstly, in the clinical field, 
diagnosis should result in avoidance of inappropriate 
medication, such as benzodiazepines, which may lead to 
increased confusion. Risk factors may also be controlled. 
Although the diagnosis and prognosis may be very 
distressing to the family, the knowledge that a relative 
is ill and not just difficult or lazy, can be helpful both 
for their relationship, and in arranging practical 
assistance. When there is no family, a diagnosis enables 
the early alerting of services, and crises may be avoided, 
so that the patient can be maintained in the community 
longer.
Secondly, for research purposes the early detection of 
dementia will allow several benefits. Natural history 
studies to determine the subgroups of the different types 
of dementia, and the characteristics of these subgroups 
become feasible. This should lead to more accurate
prognostic data. These subgroups of dementia will be
discussed below in chapter 3. In addition a more 
representative sample which includes early cases, will
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enable clearer evidence of risk factors for the dementias 
to be obtained. This applies to both genetic and 
environmental factors. Prevention of dementia, may 
ultimately be feasible when risk factors are known. 
Finally, pharmacological therapies require accurate 
diagnoses to enable accurate testing. The best hope for 
effective pharmacological treatment lies in early 
dementia, where there is less cell death.
2.5 CONCLUSIONS
1) Dementia is a symptom complex with different 
aetiologies.
2) The commonly used criteria for dementia differ from 
each other.
3) It is important to diagnose early dementia for the 
benefit of the patient and family and for future research 
progress.
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CHAPTER 3
THE SUBCLASSIFICATION AND VALIDATION CRITERIA OF 
THE DEMENTIA SYNDROMES.
32
3-1 CLASSIFICATION SYSTEMS.
Traditionally dementia was classified by age into senile 
and presenile dementia, 65 being the age used as the cut 
off. However as more aetiological factors for dementias 
became known, dementia has been classified by category 
(such as degenerative or neoplastic), and into specific 
clinicopathological diseases such as Alzheimer's disease 
and multi-infarct dementia. These latter diagnoses 
require both the clinical features of dementia, and a 
diagnosis based upon pathological examination. They can 
therefore rarely be definitively made in life, except by 
brain biopsy. This unsatisfactory situation has led to 
many attempts to formulate clinical criteria that have 
predictive validity for a particular pathological picture, 
thus improving diagnostic accuracy during life. An 
alternative strategy of finding antemortem diagnostic 
markers is also being pursued.
Another system of classification of the dementias is into 
cortical and subcortical dementia (Albert et al 1972). 
Albert coined the term subcortical dementia to describe 
the changes of progressive supranuclear palsy and 
suggested that dementia could be divided into the 
subcortical and the cortical. The term subcortical 
dementias now include the dementias of Huntington's 
disease and Parkinson's disease. They are characterised 
by a slowness of thought and movement, forgetfulness, and
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changes in personality, usually apathy and depression. The 
site of pathology is not in the cerebral cortex, but in 
the brainstem, red nucleus, thalamus and basal ganglia. 
This is in contrast to cortical dementias where pathology 
is in the cortex, and amnesia is an earlier and prominent 
symptom. In this latter category are Alzheimer's Disease, 
Pick's disease, Jacob-Creutzfeld disease and dementia 
associated with large vessel strokes.
This dichotomy, between cortical and subcortical dementia, 
has not been systematically validated and many dementias 
cross the lines between the pathologies (Chui, 1989). For 
example patients with Parkinson's disease may have Lewy 
bodies or plaques and tangles within the cortex and 
patients with Alzheimer's disease often show subcortical 
lesions. The individual neuropathological
classifications are discussed in more detail in the rest 
of this chapter.
3.2. CLINICOPATHOLOGICAL CLASSIFICATIONS OF ALZHEIMERS 
DISEASE.
The diagnosis of definite Alzheimer's Disease (A.D.) 
remains based on a clinical picture and neuropathological 
features. The clinical features and neuropathology were 
first fully described by Alzheimer in a case report on a 
51 year old woman. He described the symptoms progressing
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from jealousy towards her husband. "Soon a rapidly 
increasing loss of memory could be noticed. She could not 
find her way around in her own apartment. She carried 
objects back and forth and hid them. At times she would 
think that someone wanted to kill her and would begin 
shrieking loudly ....
If one pointed to objects, she named most of them 
correctly ... When reading she went from one line into 
another, reading the letters or reading with a senseless 
emphasis. When writing she repeated individual syllables 
several times, left out others ... When talking, she 
freguently used perplexing phrases and some paraphasic 
expressions (milk-pourer instead of cup)...
The generalised dementia progressed however. After four 
and a half years of the disease, death occurred ...
The autopsy revealed remarkable changes in the 
neurofibrils. They merged into dense bundles. Finally 
the nucleus and the cell disintegrated...
Scattered through the entire cortex ... one found foci of 
deposition of a peculiar substance." (Alzheimer 1907).
For many years the term Alzheimer's disease was used to 
refer only to pre-senile dementias of the Alzheimer's 
type, as it was thought to be distinct from senile
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dementia which was perhaps a part of normal ageing. As 
the neuropathology of the senile and pre-senile dementia 
does not differ, the term Alzheimer's disease is now used 
for both categories. The question of normal ageing is 
still current and is discussed in the next section.
3.3 ALZHEIMER'S DISEASE AND NORMAL AGEING.
Despite the recognition of Alzheimer's disease since the 
beginning of this century, and the warnings of an 
"epidemic" by the end of the century, there is still a 
debate about on the status of Alzheimer's disease as a 
discrete disease. Brayne & Calloway (1988a) reported a 
study of 70-79 year old women in rural Cambridgeshire. 
They found that that there are no discontinuities of score 
in this population, on a standardised dementia scale, 
between those with clinical dementia and those without. 
They concluded that Alzheimer's disease is at one end of 
the continuum of normal ageing, on the continuum with a 
"usual" group of the elderly having some of the 
characteristic neuropathological changes of Alzheimer's 
Disease, and a "successful" group, in terms of brain 
function having no such lesion. In a letter in reply 
Hoffman et al (1988) point out that the scale used (which 
measures cognition and behaviour) is a crude scale, which 
by its nature might blur any true bimodality of 
distribution in scores. This potential bimodality would
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be further blurred by data which derived from a whole 
population, that is, including all dementing diseases, not 
just Alzheimer's disease. In addition, although Brayne & 
Calloway have shown a continuum in results on cognitive 
testing, this does not imply a neuropathological 
continuum. Hoffman et al end by suggesting that as 
atherosclerosis rises with age, the continuum model would 
imply that vascular dementia is also part of normal 
ageing, and challenge Brayne & Calloway to give a view on 
that question. Brayne & Calloway (1988b) continue the 
debate, by stating that removing all those subjects with 
brain pathologies other than Alzheimer's disease from the 
graph did not affect the unimodal distribution of the 
results, and that the neuropathological lesions of
dementia are similarly unimodally distributed. They
conclude by calling on Hoffman et al to prove that
Alzheimer's disease is distinct from normal ageing.
This debate has little practical implications. Both sides 
agreed that whether or not Alzheimer's disease "exists" 
the clinical state which is described as Alzheimer's 
Disease has important consequences. The definition of 
this clinical state will be discussed in the next section. 
Both sides agree that aetiology may be multifactorial and 
that it is important to investigate genetic and
environmental agents. While Hoffman et al think that the 
distribution of neuropathology and cognition between 
"normals" and those with Alzheimer's disease may
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be bimodal, they do not insist that it is. The question 
which was not been addressed in this article or subsequent 
correspondence appears to be the meaning of the word 
normal. This is discussed further in Chapter 5.2.
3.4 THE CRITERIA FOR THE DIAGNOSIS OF ALZHEIMER'S 
DISEASE.
There have been several different criteria used for the 
diagnosis of Alzheimer's disease. Mayer-Gross et al 
(1969) in the Slater and Roth textbook characterise the 
presentation by a gradual, yet progressive, failure in the 
activities of daily life. Memory and intellectual failure 
dominate the early picture; dysphasia, dyspraxia and 
agnosia commonly evolve.
This clinical approach has been replicated by the criteria 
devised from the working group on the Diagnosis of
Alzheimer's Disease, from the National Institute of 
Neurological and Communicative Disorder and Stroke 
(NINCDS) and the Alzheimer's Disease and Related Disorders 
Association (ADRDA). These criteria are comparable with 
the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-III) and the International Classification of Diseases 
(ICD). They are suggested for the purpose of making
investigations in different studies comparable. The
authors explained that the criteria are tentative and
38
subject to change, as they required confirmation by
longitudinal studies and post mortem. These confirmatory
methods will be discussed in 3.5 below.
According to the NINCDS/ADRDA criteria, Alzheimer's 
disease is defined as a progressive, dementing disorder of 
middle or late life. In this definition, dementia is the
decline of memory and other cognitive functions in
comparison with the patient's previous level of function, 
as determined by a history of decline of performance and 
by abnormalities noted from clinical examination and 
neuropsychological tests. A diagnosis of dementia cannot 
be made when consciousness is impaired by delirium, 
drowsiness, stupor or coma. It is a diagnosis based on 
behaviour and cannot be determined by laboratory 
instruments.
The diagnosis of Alzheimer's Disease using these criteria 
is divided into definite, probable and possible. The 
diagnosis is definite only in the presence of both a 
clinical diagnosis and histopathological evidence. The 
diagnosis is probable when dementia is established between 
the ages of 40 and 90 in clear consciousness, in the 
absence of other systemic disorders or brain diseases that 
could account for the progressive deficits in memory or 
cognition. Alzheimer's disease is possible when there is 
a second systemic or brain disorder sufficient to produce 
the dementia which is not considered to be the cause of
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the dementia. (McKhann et al 1984).
3.5 VALIDATION OF CRITERIA FOR THE CLINICAL DIAGNOSIS 
OF ALZHEIMER *S DISEASE
Many attempts have been reported in the recent literature 
to validate clinical criteria by antemortem and postmortem 
neuropathology, by longitudinal studies and by cerebral 
blood flow studies.
3.5a NEUROPATHOLOGICAL VALIDATION CRITERIA FOR 
ALZHEIMER'S DISEASE
The first study to validate the diagnosis of dementia by 
neuropathological postmortem studies, tested clinical 
diagnoses made prior to the existence of specified 
criteria (Tomlinson et al 1970). More recent papers 
concerning the neuropathological validation have 
tested clinical criteria (Kokmen et al 1987), DSM-III 
(Forette 1989), the Mayer-Gross criteria (Wade et al, 
1987) or most commonly the criteria laid down by the 
National Institute for Neurological and Communicative 
Disorders and Stroke with the Alzheimer's and Related 
Disorders Association (NINCDS/ADRDA criteria) (Martin et 
al 1987, Morris et al 1988, Tierney et al 1988, Boiler et 
al 1989, Risse et al 1990).
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The neuropathological criteria for the diagnosis of
Alzheimer's Disease were first derived in the work of 
Tomlinson et al (1970). They compared the postmortem 
neuropathological findings of fifty patients with a 
diagnosis of dementia, who had died either in a mental 
hospital or in a geriatric unit, with the findings of 
twenty-eight non-demented old people. They considered 
the brain weight, the ventricular size, the volume of 
brain destroyed, the position of lesions, the number of 
senile plaques, the number of neurofibrillary tangles in 
the hippocampus and general cortex and the amount of 
granulo-vascular degeneration in the hippocampal pyramidal 
cells in both sets of brains. There was a bimodal 
distribution of neuropathological findings, with the 
controls and the demented group being clearly
differentiated, both in cases of Alzheimer's Disease and 
of atherosclerotic dementia. The paper states that as the 
demented group were not representative, it is not
appropriate to assume the bimodal distribution found will 
necessarily be replicated in all populations.
The important neuropathological findings to distinguish 
the groups were, 1) cerebral atrophy, 2) increased 
ventricular size. The neuropathological findings
characteristic of senile dementia of the
Alzheimer's type were:- heavy plaque formation, 
neurofibrillary change and granulo-vacuolar degeneration. 
The paper suggested criteria for Alzheimer's Disease which
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were:-
1) More than 18 senile plaques per low power field in the 
cortex.
2) Neurofibrillary changes in both the neocortex and the 
hippocampus.
Since these standards were first formulated other 
neuropathological inclusion and exclusion criteria have 
been suggested. So the 'gold standard' of
neuropathological validation, like the clinical criteria 
is varied. Clinicopathological agreement will therefore 
vary according to the neuropathological standards used. 
For example, a second pathological standard accepts 
tangles and plaques just in the hippocampus, without 
requiring changes in the cortex, as being diagnostic of 
Alzheimer's disease (Ball et al. 1985). Another 
definition states that plaques and tangles must be present 
only in the neocortex (Molsa et al, 1985), and a fourth 
that in those 66 or above, plaques without the requirement 
of tangles in the neocortex is diagnostic of Alzheimer's 
disease (Khachaturian, 1985).
Tierney et al (1988) reviews the clinicopathological 
agreement on the NINCDS/ADRDA standards using three 
different inclusion criteria for Alzheimer's disease, and 
three different criteria for exclusion of multi-infarct
G*'"
dementia. The sample consisted of 57 cases, 22 of which 
received a clinical diagnosis of Alzheimer's Disease.
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They found that the pathological agreement on the clinical 
diagnosis of Alzheimer's Disease ranged from 64%-86%. 
The classifications which specified neocortical lesions 
only and that which specified both neocortical and 
hippocampal lesions produced identical groups and 
therefore proved to be equivalent.
Having considered both clinical and pathological criteria 
for Alzheimer's Disease, the next section summarizes 
studies which have correlated them.
3.5b. CLINICOPATHOLOGICAL STUDIES OF ALZHEIMER'S DISEASE
Clinicopathological studies of Alzheimer's Disease and the 
results are summarised in Table 1.
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Morris and Fulling (1988) and Martin et al (1987) both 
find an impressive 100% correlation between their 
diagnosis of Alzheimer's disease using the NINCDS/ADRDA 
criteria and the neuropathological findings. Both groups 
used very rigorous inclusion and exclusion criteria in the 
diagnostic process. Morris and Fulling included only 
those with a gradual sustained deficit in at least three 
areas, including functioning, lasting at least six months 
and excluded all neurological, psychiatric and other 
medical disorders. Martin et al's criteria were similar 
in both inclusion and exclusion criteria. It therefore 
appears that using the NINCDS-ADRDA criteria and 
interpreting the criterion "absence of systemic disorders 
or other brain diseases that in and of themselves could 
account for the progressive deficits in memory and 
cognition" narrowly, to mean the exclusion of patients 
with all other pathologies, is an effective method of 
diagnosing Alzheimer's Disease without false positives 
being included in the group. As no autopsy results are 
reported for those not so diagnosed, the number of false 
negatives are not known. This method is not useful as a 
way of estimating the prevalence or incidence of dementia, 
or of diagnosing most patients as sensitivity may be 
traded for specificity. This is because it is rare to 
find elderly people with dementia who are otherwise 
completely well. Applying findings from a small 
specialised group to other clinical populations can be 
misleading.
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Boiler et al (1989) who find a high sensitivity and a low 
specificity of clinical diagnosis, also used the NINCDS- 
ADRDA criteria. Two neurologists interpreted the criteria 
to diagnose probable Alzheimer's Disease in all those with 
clinical dementia, when another aetiology was not found on 
thorough investigation, even if there was another disease 
present. As the diagnoses were made on clinical records, 
the information available was sometimes incomplete. 
Unexpectedly, the accuracy of diagnosis was not 
significantly different in those cases in which relatively 
little was known, than in those subjects who had been 
documented and seen repeatedly and longitudinally in the 
Alzheimer's Disease Research Centre of the University of 
Pittsburgh. However there was a trend towards less 
extensive information resulting in less accurate 
diagnoses. Most discrepancies were accounted for by 
dementias which did not have the expected clinical 
features in life, for example, progressive supranuclear 
palsy occurred in one patient without any ocular signs.
Tierney et al (1988) also used the NINCDS-ADRDA criteria. 
Their results, using the different neuropathological 
criteria listed in table 1 suggest, that Boiler's group 
employed the strictest neuropathological criteria 
available. Tierney's group diagnostic specificity is much 
higher than Boiler's. This may be because Tierney's cases 
all had comprehensive information up until death? which 
was not the case in Boiler's sample; as. the dementia
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progressed the clinical signs may have become clearer. 
Risse et al (1990) report a study of 25 male inpatients 
which is directly comparable with Martin et al (1987), 
Tierney et al ;(1988) and Boiler et al (1989), as the same 
clinical and pathological criteria were used. Like 
Tierney et al (1988), comprehensive information was 
collected until death. There was a tendency, although 
numbers were too small, for the result to be significant, 
for diagnosis to be less accurate in the under 65s. In 
addition to these studies, Burns et al (1988) give a 
preliminary report in a letter, that 30 out of 3 0 post­
mortem examinations confirmed the diagnosis of patients 
diagnosed as having Alzheimer's Disease on a narrow 
interpretation of the NINCDS/ADRDA criteria. No other 
recent studies have tried to validate the NINCDS/ADRDA 
criteria.
Studies such as Homer et al (1988) and Joachim et al 
(1988), do not state the clinical criteria used. Although 
these studies emphasise the inaccuracy of clinical 
criteria, the studies do not contribute greatly to the 
state of knowledge, as neither clinicians nor researchers 
can interpret the findings to improve diagnostic criteria.
Wade et al (1987) used the Mayer-Gross criteria to 
diagnose patients with Alzheimer's disease, with a good 
sensitivity and specificity, using less strict 
neuropathological criteria.
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Crystal et al (1988) correlated a diagnosis made on 
results of psychometry with neuropathology in 28
longitudinally evaluated subjects aged 75-85. Six of the 
subjects who were not demented according to McKhann 
criteria, had numerous plaques in the cortex at post 
mortem. However five of these patients showed cognitive 
decline in the time from the first test, suggesting that 
very mild A.D. was present before it could be diagnosed by 
accepted criteria.
Overall, it appears that the criteria for clinical
diagnosis of Alzheimer's Disease are evolving. However 
they are still vague enough to be open to different 
interpretation. While the pathological criteria are not 
vague, they differ. This can make a difference of 20% in 
results of clinicopathological correlations. In the few 
elderly people who have had no other physical illness and
present with a typical insidious, progressive and
unremitting Alzheimer's Disease, the diagnosis can now be 
made with confidence. Progress still remains to be made 
about the diagnosis in other patients. Improvements in 
clinical diagnosis may be either through the development 
of better clinical criteria or through antemortem 
diagnostic markers.
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3.5c. ANTEMORTEM DIAGNOSTIC MARKERS FOR ALZHEIMER7S
DISEASE
NINCDS-ADRDA Work Group on the diagnosis of Alzheimer's 
Disease referred to the absence of laboratory markers of 
the disease and mentioned regional cerebral blood flow 
(rCBF), electroencephalography (EEG), computerised 
tomography (CT), positron emission tomography (PET scan) 
and magnetic resonance imaging (MRI) as possibilities 
(McKhann et al 1984).
In a 1988 review of the literature, Cutler concludes that 
there is no definitive ante-mortem marker capable of 
replacing clinical examination in Alzheimer's Disease. He 
suggests that the search for a diagnostic marker should 
continue. The rest of this section will discuss work 
published since Cutler's review.
MAGNETIC RESONANCE IMAGE SCANNING
Magnetic resonance imaging (MRI) provides both anatomical 
information similar to CT neuroscans and some biochemical 
information. The parameters associated with magnetic 
resonance phenomenon T1 and T2 correlate with tissue water 
content and cellular water binding, respectively.
49
Since Cutler's 1988 review, Christie et al (1988) have 
found by MRI techniques that tissue water content (Tl), of 
the frontal lobes in patients with presenile Alzheimer's 
disease were similar to age matched controls. However the 
Tl values were raised in Korsakoff's psychosis and multi­
infarct dementia, and they concluded that MRI of Tl values 
can assist in differentiating presenile A.D. from other 
causes of presenile dementia. In this study A.D. 
diagnosis was by criteria comparable with the 
NINCDS/ADRDA, and diagnosis of multi-infarct dementia, by 
a history of stepwise deterioration and a Hachinski score 
from 8-13. Another MRI study reports biochemical changes 
in the phospholipid membrane, which reflects the activity 
of metabolic pathways (Brain et al 1989). Seventeen 
patients with Alzheimer's Disease were compared with 10 
patients diagnosed as suffering from multiple subcortical 
infarct dementia (MSID), and with seventeen non-demented 
controls. The diagnosis of Alzheimer's disease was made 
by using the NINCDS/ADRDA criteria. The MSID group were 
diagnosed by having more than one subcortical hypodensity 
on CT scan and a Hachinski score >7. It is unclear that 
these criteria correctly diagnose subcortical infarct 
disease, as hypodensities are not the same as infarcts. 
The MSID group might therefore be more accurately 
described as vascular dementia. The vascular group and 
the Alzheimer group could be distinguished on MRI scan. 
The vascular group had elevation of the phiosphocreatinine 
inorganic orthophosphate ratios (PCr/Pi) in both
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temporperietal and frontal regions. In the A.D. group 
phosphomonoesters (PMe) were elevated in frontal regions, 
and Pi was elevated in temporparietal and frontal regions. 
Values of PCr/Pi accurately classified 100% of vascular 
dementia and 92% of A.D.
These are promising preliminary studies which suggest MRI 
scan may be helpful in the differential diagnosis of 
dementia. However, the clinical diagnosis is used in 
these studies as a "gold standard", without any 
neuropathological confirmation. In addition, as the 
dementia groups are not matched for levels of cognition, 
differences found in metabolic profiles, may reflect 
differences in stages of disease. Finally, it is often 
difficult to gain co-operation for scanning from people 
with dementia, and so MRI scanning may not be a practical 
method of diagnosis in many patients.
SINGLE PHOTON EMISSION TOMOGRAPHY.
Burns et al (1989) report a study using single photon 
emission tomography (SPET). They compare twenty patients 
with Alzheimer's Disease diagnosed by NINCDS/ADRDA 
criteria with six age matched controls. The A.D. patients 
showed cerebral blood flow deficits which correlated with 
psychometric testing and distinguished them from controls. 
They did not attempt at this stage to use SPET to
51
distinguish Alzheimer's dementia from other dementias.
P300 AUDITORY EVENT-RELATED POTENTIAL
Although event-related potentials have been found to be 
abnormal in dementia and there is a correlation between 
P300 latency and psychometric tests (Wright et al 1988), 
latency changes occur in both Alzheimer's disease and 
multi-infarct dementia and do not differentiate between 
them (Neshige et al 1988).
3 • 5d. LONGITUDINAL STUDIES OF THE DIAGNOSIS OF 
ALZHEIMER'S DISEASE
Blessed and Wilson (1982) published a validation study of 
the clinical diagnosis of Alzheimer's Disease. They did 
this by comparing the outcome of those diagnosed as 
suffering from arteriosclerotic and senile dementia, and 
measured outcome as either discharge, or death, or 
remaining an inpatient. In those terms, they found no 
difference in the outcome between the two categories. 
Thus there was no confirmation in the validity of this 
subclassification.
More recently, Huff et al (1987) used the cognitive 
deficits detected by neuropsychological tests to validate
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the clinical diagnosis of probable Alzheimer's Disease 
using a narrow definition of NINCDS/ADRDA criteria. At a 
one year clinical follow up all those with a diagnosis of 
Alzheimer's disease had multiple deficits. They report 
that criteria had a sensitivity of 100% and a specificity 
of 89%. Similarly in France, Forette et al (1989) studied 
fifty five subjects who were diagnosed as suffering from 
a dementia, compatible with NINCDS/ADRDA criteria. One 
year later fifty-two subjects still had the same diagnosis 
indicating a reliability of 95%. However the reliability 
of the diagnoses over time does not prove the validity of 
the original diagnoses, this still requires 
neuropathological confirmation.
3.6. THE CRITERIA FOR THE DIAGNOSIS OF VASCULAR DEMENTIA
The phrases atherosclerotic dementia, vascular dementia 
and multi-infarct dementia tend to be used 
interchangeably. Tomlinson et al (1970) used the clinical 
diagnostic term "atherosclerotic dementia", for which they 
provided neuropathological validation by measuring the 
volume of infarcted tissue in the brain. However, 
Hachinski et al (1974) argued that this term had led to 
common medical misdiagnosis and over diagnosis of vascular 
dementia, as an image existed in many minds of 
atherosclerosis causing a relentless strangulation of the
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brain's blood. They review the literature, concluding 
that atherosclerosis of the basal vessels of the brain 
does not by itself play any decisive role in the 
manifestation of dementia in old age. Instead, most 
vascular dementias are caused by cerebral infarcts 
secondary to emboli from extracranial arteries and the 
heart. Therefore they suggested the term "multi-infarct 
dementia", (MID) to define dementia caused by a series of 
infarcts. Hachinski believed this term would prevent 
over-diagnosis of atherosclerotic dementia because of a 
mistaken conceptual framework.
By 1988, however O'Brien was arguing that using the term 
multi-infarct dementia synonymously with the term vascular 
dementia, results in underdiagnosis of vascular dementia, 
as small vessel disease (Binswanger's disease or 
subcortical arteriosclerotic encephalopathy) is missed. 
In this thesis "multi-infarct dementia" will be used 
either as Hachinski defined it, or when quoting papers 
which use the term multi-infarct dementia. Vascular 
dementia will be used to include small vessel disease or 
again as it is used in published work. The evidence for 
underdiagnosis of small vessel disease will be discussed 
in the rest of this chapter.
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3.6a. CLINICAL CRITERIA FOR THE DIAGNOSIS OF VASCULAR
DEMENTIA
No comparable criteria to the NINCDS/ADRDA criteria for 
Alzheimer's disease have been developed for multi-infarct 
dementia. The DSM-III-R criteria for multi-infarct 
dementia are A. Dementia B. Stepwise deteriorating 
course with "patchy" distribution of deficits ( i.e. 
affecting some functions but not others) early in the 
course. C. Focal neurologic signs and symptoms. D. 
Evidence from history, physical examination, or laboratory 
tests of significant cerebrovascular disease that is 
judged to be aetiologically related to the disturbance. 
This last criteria is described by Brust (1988) as a 
combination of ischaemic score and gut response. "You may 
blame dementia on the stroke if you think the stroke 
caused the dementia".
Similarly ICD-9 defines arteriosclerotic dementia as 
dementia attributable, because of physical signs (on 
examination of the central nervous system) to degenerative 
arterial disease of the brain. Symptoms suggesting a 
focal lesion in the brain are common. There may be a 
fluctuating or patchy intellectual defect with insight, 
and an intermittent course is common.
More often the Hachinski Ischaemic Score (also known as 
the HIS, Ischaemic Score or the Hachinski Score) is used
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as a diagnostic tool for multi-infarct dementia. This 
method of scoring was derived by Hachinski et al (1975) 
from the criteria outlined by Mayer-Gross et al, (1969) 
for multi-infarct dementia. It includes a list of 
thirteen features which are likely to occur in M.I.D., 
such as acute onset, stepwise deterioration and focal 
neurological signs. These items are scored positively so 
that the higher the score, the greater the probability of 
ischaemic dementia.
The paper describes a group of twenty-four demented 
patients. Patients with secondary dementia were excluded 
from this group by history, physical and laboratory 
examination, scan and EEG. The diagnosis of multi-infarct 
dementia was validated according to regional cerebral 
blood flow studies, using intracarotid 133 Xenon 
injection. The regional pattern of flow was deemed 
abnormal when it differed by 3.3 standard deviations from 
the value of the equivalent area in brains of controls, 
and abnormally low CBF was deemed to be diagnostic of 
multi-infarct dementia.
Application of the Ischaemic Score separated the patients 
clearly into two groups without any overlap. Patients 
scored seven or above were classified as having multi­
infarct dementia, and patients scoring 4 or below who were 
not. No one scored between 4 and 7. The patients with a 
diagnosis of multi-infarct dementia showed a significant
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decrease in cerebral blood flow per 100 gin brain per 
minute. An inverse relationship between C.B.F. and the
degree of dementia was found to be present only in the 
multi-infarct group. No neuro-pathological confirmation 
was attempted. The place of cerebral blood flow in 
validating the clinical diagnosis of vascular diagnosis is 
discussed below.
3.6b CEREBRAL BLOOD FLOW AS VALIDATION OF THE DIAGNOSIS 
OF VASCULAR DEMENTIA
Hachinski used cerebral blood in 1975 to validate his 
Ischaemic Score. Since then controversy over the cerebral 
blood flow in dementia has continued. O'Brien (1986,1988) 
believes that cerebral blood flow (CBF) per unit mass 
falls only in early vascular disease. He argues that 
CBF/unit mass remain constant in Alzheimer's disease, 
although the total CBF would fall in parallel with the 
loss of tissue bulk, but in early vascular dementia, 
healthy neurones are impaired by inadequate blood supply, 
and eventually they die. In contrast to Hachinski, he 
argues that a state of "chronic ischaemia" exists which 
causes dementia. Cerebral cortex perfusion rates are 
therefore likely to be reduced early in the disease and 
out of proportion to the dementia. In late stages both 
A.D. and vascular dementia would show both a reduced flow, 
because of less metabolism and a reduced cell mass.
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Rogers et al (1986) support O'Brien's viewpoint. They 
note reduced cerebral perfusion in high risk patients 
prior to the onset of dementia, and attribute it to 
"subclinical cerebral atherosclerosis". In contrast, when 
Deutsch & Tweedy (1987) studied cerebral blood flow in 15 
patients with Research Diagnostic Criteria Alzheimer's 
Disease, 15 patients with M.I.D. (Hachinski score 7+) 
matched for the severity of cognitive symptoms, and 15 
normal volunteers, they found a significantly lower C.B.F. 
in the AD disease patients than the M.I.D. group.
Brust (1988) argues that O'Brien is wrong about cerebral 
blood flow. If O'Brien's theory was correct, this would 
imply: 1) cerebral vasodilators or hyperbaric oxygen
should offer therapeutic benefit to sufferers from 
vascular dementia. They do not. 2) that this 'misery 
perfusion' should lead to neurological symptoms triggered 
by any fall in blood pressure. This is not the case.
In summary, cerebral blood flow is not a clear cut way of 
making or validating the diagnosis of multi-infarct 
dementia or vascular dementia. Only one study of cerebral 
blood flow reinforces O'Brien's (1988) contention that 
vascular dementia is underdiagnosed because the chronic 
underperfusion due to cerebral atherosclerosis often 
exists, but is not considered. If those patients do 
exist, decreased cerebral blood flow prior to clinical 
dementia could still result from multiple emboli, or
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infarctions rather than be the cause of vascular dementia.
3.6C. NEUROPATHOLOGICAL CRITERIA FOR VASCULAR DEMENTIA
Neuropathological examination has also been used to 
validate the diagnosis of vascular dementia. Tomlinson et 
al (1970), in their post-mortem comparison of the brains 
of patients with dementia, with the brains of those not 
suffering from dementia, found a pathological finding of 
100 millilitres of brain destroyed, correlated in all 
cases with dementia. In most cases 50 mis of destroyed 
brain also correlated with this diagnosis. Multiple small 
diencephalic infarcts were seen as often in patients with 
or without dementia. In cases with the diagnosis of 
arteriosclerotic dementia, the small diencephalic infarcts 
were never the dominant lesion. Therefore these 
subcortical lesions were not regarded as important in the 
diagnosis of dementia. Since then, many studies have used 
the finding of 50 mis of infarcted brain tissue as the 
"gold standard" to confirm the diagnosis of multi-infarct 
dementia. More recently, a report has been published 
that in autopsies of thirty-two demented and sixty- 
eight non-demented patients over sixty, the frequency of 
cerebral infarcts was significantly higher among the non­
demented patients (Kokmen et al, 1987). This finding has 
to be regarded sceptically, as it was based on a 
retrospective clinical diagnosis, made on case notes of
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patients, not specifically investigated for dementia. 
Although the diagnosis of dementia is likely to be 
justified in the "cases" who were nearly all 
institutionalised, the other patients may have had a 
dementia which was not documented. This is borne out by 
the fact that 35% of the "non-demented" had plaques or 
tangles at autopsy.
However the position regarding neuropathological 
confirmation of vascular dementia is similar to 
Alzheimer's disease in that there are now varying 
pathological criteria in use to confirm the diagnosis of 
multi-infarct dementia. Tierney and colleagues (1988) 
cite three sets of pathological criteria currently in use 
to diagnose dementia. These are firstly, the Tomlinson et 
al (1970) criteria of ischaemic lesions totalling 50 mis 
or more of brain tissue in the neocortex. Secondly, any 
ischaemic lesion irrespective of size or site. Thirdly 
any ischaemic lesion in the neocortex, subcortical white 
matter and/or hippocampus. In a post-mortem these 
criteria can lead to varying clinico-pathological 
correlations, as described in more detail in the next 
section.
3 . 6d CLINICO-PATHOLOGICAL STUDIES OF MULTI-INFARCT 
DEMENTIA.
These studies are summarised in Table 2.
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The few studies that exist vary in method, but overall the 
sensitivity and the specificity of the diagnosis of multi­
infarct dementia does not appear to be as good as for 
Alzheimer's disease. Much of this can be accounted for by 
two factors: 1) the difficulty in differentiating multi­
infarct dementia and mixed dementia, using the Hachinski 
score, and 2) the varying pathological and clinical 
criteria for multi-infarct dementia.
The pathological criteria used by Molsa et al (1985) did 
not include quantification of any ischaemic lesion, so 
that authors believe that "their significance for the 
mental deterioration may have been negligible". This 
seems likely, in view of Tomlinson et al (1970) finding 
that multiple diencephalic infarcts do not signify 
dementia. In Molsa et al's study the Hachinski score was 
64% successful (29/45) in classifying patients into three 
groups, A.D.(Hachinski score 4 or less), mixed dementia 
(Hachinski score 5 or 6), and multi-infarct dementia 
(Hachinski score 7 or more). The multi-infarct dementia 
and combined groups were not properly distinguishable on 
the basis of the Hachinski score. The best result was 
obtained with a logistic regression model which identified 
correctly 82% of cases (37/45). The model included 
fluctuating course, nocturnal confusion and focal 
neurological symptoms as the best discriminating score 
variables. A similar finding in another study was that 
the Ischaemic Score did not differentiate between the
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M.I.D. patients and those with mixed dementia, (Wade et al 
1987) . However 35 out of 38 cases of pure Alzheimer's 
disease had a Hachinski score of <4. Homer et al (1988) 
also used the Hachinski score with the idiosyncratic 
interpretation of the item "relative preservation of 
personality" as meaning the presence of insight. All four 
patients who had a Hachinski score >7 had multi-infarct 
dementia. However twelve other patients had multi-infarct 
dementia and their Hachinski scores varied from zero to 
six.
In summary, most patients with a Hachinski score of > 7 in 
these studies, had either multi-infarct dementia or mixed 
dementia, and most with H.I.S. < 4 did not. However the 
H.I.S. did not distinguish between multi-infarct dementia 
and mixed dementia. The results of computerised 
tomography neuroscans have been used in some of the 
studies in table 2 as aids to the diagnosis of vascular 
dementia. The next section discussed the use of CT Scans 
and other neuroimaging in this field.
3•6e VALIDATION OF VASCULAR DEMENTIA BY BRAIN IMAGING 
COMPUTERISED TOMOGRAPHIC NEUROSCANS
Discrete infarctions can sometimes be seen in CT scan and 
enable the diagnosis of multi-infarct dementia to be
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confirmed, although the presence of infarcted tissue does 
not exclude any co-existing disease. These infarcts are 
seen as well demarcated wedge-shapes which follow specific 
vascular territory and usually extend to the cortex. 
There is enlargement of the upsilateral ventricle or 
sulcus. All these features contrast with deep white 
matter hypodensities commonly seen in CT and MRI scan 
(Steingart et al 1987).
Hachinski et al (1987), discuss the significance of these 
hypodensities in the first of a series of four papers. 
They believe that hypodensities do not signify 
Binswanger's Disease, of which there are fewer than 50 
pathologically proven cases in the world literature. "We 
are witnessing the unfounded attribution of a specific 
pathologic cause to increasingly more sensitive images of 
the brain". They suggest the term Leuko-Araiosis (L.A.) 
from the Greek words leuko - meaning "white" and araio 
meaning "rarefied", or "of loose texture" should be used 
as a precise description of these hypodensities. If the 
term L.A. comes into use, the authors believe it will 
eventually lead to an aetiological subclassification of 
these CT lesion, so that the L.A. classification term 
becomes redundant.
The three papers immediately following the discussion 
paper, clarify the significance of L.A. in CT scans. 
Paper two presents a study of leuko-araiosis in 105
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healthy volunteers aged 59-91. Subjects were excluded if 
they had evidence of dementia (DSM III criteria), or had 
had a stroke. The nine subjects (8.6%) with L.A. had 
significantly lower scores on psychometric testing, and 
were significantly more likely to have abnormal 
neurological signs, in the form of abnormal gait, limb 
power, planter response and primitive reflexes. These 
results suggested that leuko-araiosis might represent a 
marker for early dementia, before a DSM III diagnosis 
could be made (Steingart et al 1987).
The third paper reported the investigation of patients 
referred to the University of Ontario dementia study with 
suspected dementia. 113 patients with Hachinski ischaemic 
score <4, had a CT scan. Clinical diagnosis was made on 
all 113 patients, but no criteria are specified. However 
the diagnosis was confirmed in twenty out of twenty-one 
patients who had had an autopsy. CT changes of L.A. were 
found in 35% patients with dementia. Leuko-araiosis was 
significantly associated with older age, hypertension, 
reduced limb power and extensor planter responses. 32% of 
patients with the diagnosis of Alzheimer's disease, 75% 
with mixed dementia and 30% of other dementia categories 
had L.A. Throughout the series of patients taken as a 
whole, the presence of L.A. did not predict a worse 
dementia. However in mild Alzheimer's Disease (classified 
by score on the psychometric test used, the extended scale 
for dementia) those with leuko-araiosis tended to have
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more impairment (Steingart et al 1987).
In the last of this series Inzitari et al (1987) compare 
some of the patients in the two previous papers in a 
search for risk factors for leuko-araiosis and to clarify 
further the link between L.A., dementia, 
subclassifications of dementia and the Hachinski Ischemic 
Scale. Although in an univariate analysis leuko-araiosis 
was strongly associated with dementia, in logistic 
regression analysis, a history of stroke was the single 
most powerful predictor of leuko-araiosis. This history 
did not entirely explain the finding. The paper suggests 
that leuko-araiosis may be caused by "incomplete 
infarction", and note that this is consistent with the 
pathological observations by Tomlinson et al (1970) of a 
substantial proportion of cases with deep infarcts among 
patients with typical clinicopathological Alzheimer's 
disease. It is also consistent with reports that in some 
Alzheimer's patients at post-mortem subcortical vascular 
disease accounted for the subcortical lucencies (George et 
al 1986).
Independently of the Ontario group, Aharon-Peretz et al 
(1988) scanned 31 patients with a clinical diagnosis of 
M.I.D, diagnosed using DSM-III criteria and an ischaemic 
score >7. They also scanned a group diagnosed as having 
probable Alzheimer's disease on NINCDS/ADRDA criteria. 
The two groups were comparable in age and severity of
66
dementia. CT scans were evaluated blindly for ventricular 
dilation and the presence and severity of L.A., and for 
the presence and location of infarctions. The severity of 
L.A. was also evaluated using a 4 point rating system. 
LA-0 no visible lucencies, LA-1, lucencies confined to 
anterior or posterior parts of the ventricles, LA-2 
anterior or posterior perventricular lucencies, LA-3 
continuous periventricular lucencies. 97% patients with 
M.I.D. and 56% of patient with Alzheimer's Disease had 
L.A. There was no correlation between severity of L.A. 
and severity of dementia. However infarction was 
significantly more likely in the M.I.D. group than the 
rest of the demented group, as 87% of the M.I.D. patients 
had infarction on their CT scan. In M.I.D. enlargement of 
the ventricles was associated with more severe dementia, 
but not in A.D.
This study is consistent with the earlier studies in that 
L.A. is found in A.D., but less commonly than in M.I.D. 
In summary L.A. appears to be associated with risk factors 
for vascular dementia rather than specifically diagnostic 
of subcortical vascular dementia. Therefore a focal
infarction remains the main way of distinguishing M.I.D. 
and A.D. on CT scan.
These conclusions are supported by a report by Masdau et 
al (1989) of CT scans on 40 subjects in a nursing home;
20 of whom had episodes of falling, still unexplained
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despite extensive investigation, and 20 controls. Controls 
were matched for age, sex, level of education and physical 
health. All subjects underwent physical examination, 
blood tests, E.C.G. and all were rated on the Blessed 
Dementia Scale. Diagnosis of dementia was made by 
neurologists according to DSM III and NINCDS/ADRDA 
criteria.
More fallers were demented than controls (66.7% vs 25%), 
and fallers had significantly more white matter 
hypodensity than controls. On univariate analysis white 
matter hypodensity did not correlate with tests of 
cognition, although it correlated with poor gait and 
balance. Logistic regression analysis confirmed these 
findings.
MAGNETIC RESONANCE IMAGING
Magnetic resonance imaging (MRI) visualises leuko-araiosis 
more sensitively than CT scan (Erkinjuntti et al. 1987). 
Similar patterns to CT scanning are found, in that 100% of 
patients with a diagnosis of vascular dementia have leuko- 
araiosis in MRI, but so do many with non-vascular dementia 
(Merskey et al. 1987, Harrell et al. 1987, Erkinjuntti et 
al. 1987).
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3.7a. THE DIAGNOSIS OF MIXED DEMENTIA.
After considering the diagnoses of Alzheimer's Disease and 
of vascular dementia, the diagnoses of those diseases 
together, in the same person is discussed in this section.
Mixed dementia is usually taken to mean dementia which is 
due to both underlying Alzheimer's Disease and a vascular 
dementia. The diagnosis is therefore subject to the 
problems of diagnosing both Alzheimer's Disease and 
vascular dementia. The "gold standard" is again 
neuropathological confirmation. No DSM-III-R criteria are 
given for the diagnosis. Research groups use varying 
criteria for the clinical diagnosis.
These are:-
1) Primarily occurring progressive deterioration of 
memory and other cognitive functions and Hachinski 
score of 5 or 6 (Molsa et al. 1985).
2) Patients with progressive cortical dementia, plus a 
history of strokes or focal neurological signs on 
examination (Wade et al. 1987).
3) Unspecified clinical criteria (Homer et al. 1988, 
Tierney et al. 1988, Boiler et al. 1989).
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3.7b. NEUROPATHOLOGICAL VALIDATION CRITERIA FOR MIXED 
DEMENTIA
The three small validation studies for mixed dementia are 
summarised in Table 3. It is difficult to draw
conclusions from the small numbers studied. The low
sensitivity of the first study may be due to their 
pathological criterion being over-inclusive i.e. 'any 
vascular lesion'. (Molsa et al 1985). Many ischaemic 
lesions do not cause dementia (Tomlinson et al. 1970). 
As the final study does not specify the criteria they use 
their results are not helpful in improving the diagnosis 
of multi-infarct dementia (Homer et al 1988).
3.8. DEMENTIA AND PARKINSON'S DISEASE
There have been several recent reviews of dementia and 
Parkinson's Disease (Hulley and Mindham 1988, Gibb 1989, 
Baldwin & Byrne, 1989). James Parkinson's 1817 original 
description of 'shaking palsy' described "absence of any 
injury to the senses and to the intellect". However by 
1923 Lewy's monography on Parkinson's disease (P.D.) 
recorded psychiatric complications in three-quarters of 
patients. The prevalence of dementia in P.D., when the 
age of onset is over 60 years old, is now estimated to be 
10-20%. Alzheimer's disease may be coincident with P.D., 
in up to half of these cases. The clinical diagnosis of 
dementia in Parkinson's Disease is difficult, as motor 
impairment is characteristic of the disease. This makes 
results of neuropsychological tests such as ■ the
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performance scale on the Weschler Adult Intelligence Scale 
(W.A.I.S.) difficult to interpret. The neuropsychological 
tests most suitable for testing for dementia in patients 
with Parkinson's disease are visuospatial and orientation 
tasks. However clinical distinction between cortical Lewy 
body dementia and P.D. with Alzheimer's Disease is not 
possible, as both have the motor symptoms of Parkinson's 
Disease and a cortical dementia with a similar history of 
gradual decline.
Confirmation of the diagnosis of P.D. dementia is 
clinicopathological. Lewy bodies in the substantia nigra 
are the pathological hallmarks of P.D. dementia. In 
patients with P.D. dementia, there is significantly 
greater nucleus basalis cell loss than in the non-demented 
patients with P.D. (60% v 32%). In some P.D. patients 
with dementia, Lewy bodies are also present in the 
neocortex, so that the dementia of PD cannot be truly 
classified as subcortical. In others there is co-existent 
A.D.. The prevalence of A.D. neuropathological findings 
in P.D. appears to be no greater than would be found by 
chance. There are no neuropathological validation studies 
of a series of patients with a lifetime diagnosis of 
dementia of P.D. and therefore no agreed quantitative 
neuropathological criteria.
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3.9 THE DIAGNOSIS OF OTHER DEMENTIAS.
Aside from the degenerative and vascular dementias, 
dementias can be due to all the classic categories of 
disease. Diagnosis is usually that of the aetiological 
factor and there are no specified criteria. For example, 
a metabolic dementia due to hypothyroidism require thyroid 
function tests for diagnosis. In the case where the 
primary disease was treatable, diagnostic validation would 
take place if the dementia was reversed. Similarly a 
dementia due to a neoplastic space occupying lesion, would 
be diagnosed by neuroimaging, or a nutritional vitamin B12 
and folate deficiency, by full blood count and low serum 
B12 or folate.
Many secondary dementias may not be reversible. This 
would apply to some infectious dementias, like Acquired 
Immune Deficiency Syndrome Encephalopathy (AIDS), and 
sometimes to dementia secondary to alcohol or other 
intoxicant abuse.
3.10 CONCLUSIONS
1) Alzheimer's disease is a clinicopathological
diagnosis. However currently clinical and
pathological criteria vary between studies.
Nevertheless it is now possible to diagnose
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Alzheimer's Disease in people who are otherwise well, 
accurately, using a narrow definition of the
NINCDS/ADRDA criteria. This diagnosis has a high
specificity but there are still no operational 
diagnostic criteria, with both a high sensitivity and 
specificity in diagnosis.
2) Vascular dementia encompases both multi-infarct
dementia and small vessel dementia. There are still 
widely varying clinical and neuropathological 
diagnostic criteria. Computerised tomography and 
magnetic resonance imaging have enabled leuko- 
araiosis to be visualised during life. It is found in 
a large proportion of patients with dementia. It 
correlates most strongly with a history of stroke. 
L.A. may be due to incomplete infarction. Some argue 
that this appearance on neuro-imaging is diagnostic 
of small vessel dementia but this claim has yet to be 
justified. The many uncertainties in the diagnosis of 
vascular dementia mean that estimates of the 
prevalence rates can range from rare to epidemic. 
Preliminary standardisation of diagnosis needs to be 
made explicit.
3. More research is required into the subclassification 
and validation criteria of dementia syndromes, 
especially the non-Alzheimer's dementias. The 
preliminary work on neuro-imaging reviewed above, 
appears promising.
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CHAPTER 4
THE DIFFERENTIAL DIAGNOSIS OF PRESUMPTIVE DEMENTIA
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4.1 THE DIFFERENTIAL DIAGNOSIS OF DEMENTIA - CROSS 
SECTIONAL EVALUATION
After comprehensive evaluation of patients with presumptive 
dementia, up to 17% have been found not to be demented 
(Clarfield 1988). Marsden and Harrison (1972) published 
the first study which recorded a more detailed diagnosis, in 
a series of patients referred to the hospital with a 
presumptive diagnosis of dementia. They judged fifteen per 
cent of the subjects not to be demented, but to be suffering 
from a functional psychiatric disorder or another organic 
syndrome. The most common diagnosis in this group was 
depression. Similarly in a meta-analysis of thirty-two 
clinical studies which investigated the diagnoses of a series 
of subjects with presumed dementia, there was an overall 
prevalence of 4.5% of subjects suffering from depression 
(Clarfield 1988). It was not clear whether some of those 
subjects had co-existing dementia, or whether depression 
mimicked dementia (pseudodementia). Overall the pattern 
replicated Marsden and Harrison's finding that depression was 
one of the two most common condition mistaken for dementia.
Despite this evidence of misdiagnosis, in some cases 
depression and dementia do co-exist (Reifler et al 1982).
It may be that sometimes the diagnosis of pseudodementia is
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mistaken, for example, in one study, 57% of those diagnosed 
as suffering from depressive pseudodementia developed 
dementia over the next 3 years (Reding et al 1985). An 
overview of depression in Alzheimer's disease quotes thirty 
studies. Prevalence of affective symptoms ranged from 0% to 
87% (median 41%) (Wragg and Jeste 1989). The lower
prevalence tended to be found among non-hospitalised, and 
therefore perhaps more representative groups of patients. 
When 'depression' meant a specific disorder e.g. major 
depression, bipolar disorder, dysthymic disorder, and not an 
isolated mood disturbance, most prevalence figures lay 
between 10% and 20%. Similarly using more recent 
NINCDS/ADRDA and DMS-III-R criteria of depression, to make 
a diagnosis, a prevalence rate for major depression of 17% 
in a series of 144 outpatients with Alzheimer's disease was 
found. (Rovner et al 1989).
In addition a preliminary one year longitudinal study of 
matched patients, ten of whom had Alzheimer's Disease and met 
DSM-III-R criteria for major depression and ten with 
Alzheimer's Disease only, has taken place. Although the 
former group of patients satisfied both diagnostic criteria 
at outset, the diagnosis of major depression, which might 
suggest a pseudodementia did not affect the pattern of 
severity of neuropsychological deficits at one year, which 
was the same in both groups (Lopez et al 1990). The
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longitudinal outcome of Alzheimer's Disease will be discussed 
further in Chapter 4.2.
It appears therefore that the decision to allocate a patient 
either a single diagnosis of dementia or of depression may 
be misleading. This finding is further illustrated by the 
discovery that a proportion of elderly patients with a 
clinical diagnosis of affective disorders have 
neuroradiological evidence of ventricular enlargement, more 
usually associated with degenerative brain disease, further 
blurring the boundaries between these conditions (Dolan et 
al 1985). Recently the predictive validity and concurrent 
validity of a forced choice category between dementia and 
depression in the very old (mean age 83) has been examined 
(Ames et al 1990). The two clinical diagnostic subgroups 
could not be distinguished by neuroradiological appearance 
on computerised tomography and there was no difference in 
outcome at one and two year follow up. This finding from a 
group of 34 institutionalised very elderly people, cannot be 
generalised to imply that there is no difference between 
depression and dementia in all old people, but it does 
illustrate that a categorical classification may not be 
appropriate in all circumstances.
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Other final diagnoses in patients with presumptive dementia 
have been:
1) in the category of functional disorders: hypomania,
hysteria (Marsden & Harrison 1972) and schizophrenia 
(Smith & Kiloh 1981).
2) in the category of other organic syndromes: drug
toxicity, Korsakoff's psychosis, delirium, dysphasia, 
epilepsy and hepatic failure (Smith & Kiloh 1981).
4.2a. THE NATURAL HISTORY OF DEMENTIA
The diagnosis of dementia can be considered either cross 
sectionally as a differential diagnosis, or longitudinally 
in follow-up studies. The first follow-up study of patients 
with a diagnosis of dementia found that 35 of 50 patients 
discharged from hospital with a diagnosis of pre-senile 
dementia, could be traced 5-25 years later. (Nott and 
Fleminger 1975). 15 had deteriorated as expected and many
had died but 2 remained unchanged and 18 had improved. The 
paper concluded that the original diagnosis had been wrong 
in more than half the patients. The patients wrongly 
diagnosed, consisted mainly of people with marked personality 
difficulties and severe neurotic or affective disorders, most 
of whom still showed chronic psychiatric disability on 
follow-up. Ron et al (1979) carried out a similar 5-15 year
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follow-up on 51 patients discharged from the Maudsley 
Hospital with a diagnosis of presenile dementia. After 
follow-up examination, seven were suffering from a functional 
disorder, and nine had organic diagnoses which had not 
progressed, therefore there was a total of 16(31%) in which 
the authors rejected the original diagnoses. A previous 
history of affective disorder and the presence of overt 
depression at initial interview were the best predictors of 
a change in the diagnosis at follow-up.
The conclusions of these two studies are based on the 
assumption that dementia must be progressive. However as the 
natural history of dementia is not known, this assumption is 
still being investigated. A review on the literature on the 
natural history of dementia revealed ten papers which 
reported original data on these conditions (Wilson et al 
1987) . Of these studies, only one study was based on an 
inception cohort ”the most fundamental requirement for a 
natural history study” (Larson et al 1984). This study was 
also the only study performed on subjects who had not been 
inpatients in specialist centres, who are likely to be 
unrepresentative of all dementia sufferers. The study was a 
prospective analytic survey of 107 referrals to the internal 
medicine department, of patients over the age of 60 with 
cognitive impairment, mainly by the community old age 
psychiatry service, and as such was also subject to referral
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bias (Larson et al 1984). Potentially reversible causes of 
dementia were identified in 15 of the original cohort. 
These were medication toxicity (6), hypothyroidism (4), 
subdural haematoma (2), transient ischaemic attacks (1), 
manic-depressive psychosis (1), and rheumatoid vasculitis 
(1). After treatment three patients regained normal 
cognition and eleven improved partially. On two year follow- 
up, eight of those diagnosed as suffering from a reversible 
dementia showed cognitive deterioration, four did not and 
two could not be found. Five patients from the remaining 92 
had improved cognition but still remained demented at follow 
up. This was attributed to treating co-existing conditions. 
The authors of the study felt that a useful way of improving 
cognition in dementia, in general, was to treat co-existing 
conditions, rather than continue the search for reversible 
dementias.
4.2b THE NATURAL HISTORY OF ALZHEIMER'S DISEASE
Many papers consider the natural history of Alzheimer's 
Disease only, rather than the whole range of dementias. 
Since Wilson et al's review (1987), Heymen et al (1987) have 
published a prospective follow-up study of 92 white non­
institutionalised patients with a diagnosis of pre-senile 
Alzheimer's disease compatible with NINCDS/ADRDA criteria.
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Five year mortality rate was 24% compared with the expected 
rate of 9.5%. 63% were admitted to nursing homes, and those
patients were also more likely to die. Death and 
institutionalisation were predicted by severity of dementia 
and younger age at diagnosis. All the patients remained 
demented, but it is not specified whether all deteriorated 
or not. Botwinick et al (1986) report a four year follow up 
study of 18 patients diagnosed as suffering from mild 
Alzheimer's dementia. Thirteen declined and five remained 
stable. The authors suggested that these five might 
represent a group of slow or non-progressive Alzheimer's 
disease. A third longitudinal study of Alzheimer's disease 
studied 16 patients aged 52-96 years with either possible or 
probable Alzheimer's disease according to NINCDS/ADRDA 
criteria (Katzman et al 1988). It found the mean annual rate 
of deterioration on the psychometric test used was similar 
whatever the initial error score, and was independent of the 
patient's sex, education or age. The group suggested that 
an average time period of 5.2 years could be specified from 
the onset of overt cognitive change to moderately severe 
dementia. Despite the constancy of mean rates there were 
wide individual variations in the rates of progression. 
Some patients had markedly rapid progression of more than 
three times the mean, while some improved or remained stable. 
Improved scores tended to be accounted for by improvement in 
orientation in time questions.
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Similarly Teng et al (1987) found that the rate of decline 
on mini mental state examination was the same for early (age 
53-64 years) and late onset (age 65-96 years) group of 
Alzheimer's Disease. However the early onset group performed 
more poorly than the late onset group on items that tested 
for language and visuoconstructive abilities. A later study 
found that in 86 patients with NINCDS/ADRDA diagnosed 
probably Alzheimer's disease age range 46-89, that age of 
onset did not significantly affect the rate of progression 
over one year (Becker et al 1988). However, if syntactical 
impairment of language was present in early Alzheimer's 
disease, this predicted a faster deterioration. Lexical and 
semantic impairment did not. Another study found that in 
178 patients with NINCDS/ADRDA diagnosed Alzheimer's disease, 
cognitive deterioration over 12 months, was predicted by 
visual hallucinations but not by delusions (Burns et al 
1990).
In summary, there are no reports in the literature of the 
natural history of an unselected community sample with 
dementia. The studies which have been reported confirm the 
clinical impression of a varying but usually slow decline and 
early death in dementia and stability of diagnosis, in 
patients diagnosed as outpatients. The questions either of 
different courses in pre-senile and senile dementia of the
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Alzheimer's type or of factors predicting decline have not 
been resolved.
4.3. CONCLUSIONS
1) Present information on the diagnosis of dementia, suggest 
that a diagnosis of dementia indicates that the patients' 
cognitive state is unlikely to improve and will probably 
deteriorate over a period of years. It is not known what 
factors predict deterioration, although age, sex and 
severity of impairment are possible predictors. 
Improvement may be brought about by treating concurrent 
physical illnesses.
2) Screening studies are required in the community to obtain 
representative samples of subjects with dementia. These 
studies require a second phase to subclassify patients 
according to specified criteria. Using representative 
community samples, it will be possible to determine the 
relative prevalence of the dementias, and allow further 
studies of risk factors and natural history. This is 
probably the way that much progress will be made in the 
classification, aetiology, diagnosis and treatment of 
dementia, the epidemic of our time.
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3) Longitudinal studies of the natural history of the 
dementias in unselected community samples are 
required. These will improve the subclassification 
of dementia by testing the validity of current 
diagnostic systems. They will also provide valuable 
prognostic data for patients, families and service 
planning.
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CHAPTER 5 
THE EPIDEMIOLOGICAL STUDY
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5.1. HISTORY OF EPIDEMIOLOGY.
The previous chapters have considered the ageing population 
and the diagnosis of dementia. The next chapters combine 
these topics to consider epidemiology with respect to 
dementia.
The historical origins of epidemiological psychiatry have 
recently been reviewed by Bynum (1989). The word 
epidemiology probably dates from around 1850, when the London 
Epidemiological Society was formed to stimulate interest in 
epidemiology, which was defined by J P Parkan as being the 
study of "the remoter causes of epidemic diseases". The 
first paper in the society's transactions of any psychiatric 
relevance, did not appear until 1901-2 session when Frederick 
Mott published his study on 'Dysentery in Asylums'.
The study of epidemiological psychiatry was not at that time 
recognised. Despite this Daniel Hack Tuke's Dictionary of 
Psychological Medicine (1892) had articles on 'Epidemic 
Insanity', 'Statistics of Insanity' and on 'suicide' all of 
which contain epidemiological data. This data arose mainly 
from studies of asylums. Nevertheless Tuke discusses many 
problems which are relevant today. He recognised the 
concepts of prevalence and incidence, using the terms 
existing and occurring insanity; the problems of recognising
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and defining a case; the existences of 'borderline cases' 
and the influence of sociodemographic status.
Currently, epidemiology may be defined as the study of the 
distribution of morbidity in time and place, and of the 
factors which influence this distribution (Kay & Bergman 
1980). As this definition shows, the current use of the word 
epidemiology has been widened from the study of epidemics, 
to the study of all branches of medicine. It is concerned 
with the definition, classification, aetiology, prevalence, 
incidence and natural history of disease in a community. 
Since the Victorian era research using epidemiological method 
has been carried out in many areas of psychiatric illness 
including personality disorder, (eg. Mann et al 1981), the 
neuroses, (eg. Weissman & Myers 1978), psychosomatic 
disorders and the psychoses, (eg. Cooper & Sartorius 1977). 
It has also been used to study specific populations and their 
vulnerability to mental illness, for example women (eg. 
Murray et al 1981) and the elderly.
The first community survey of dementia was carried out in 
Sweden (Essen-Moller et al 1956). In the UK, the first 
reported community survey in the field of old age psychiatry 
came from a Scottish rural practice (Primrose 1962). Between 
1945 and 1985, 47 epidemiological studies of the elderly in 
the community were published (Jorm et al 1987). These and
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subsequent studies have used many different strategies for 
investigating prevalence rates and it is only by close 
scrutiny of these methods, that any broad conclusions can be 
drawn.
5.2. THE EPIDEMIOLOGICAL METHOD
5.2a. THE STUDY OF POPULATIONS
As epidemiology is the study of groups or populations rather 
than individual patients, it requires different methods of 
investigation from the traditional model of differential 
diagnostic taught in clinical medicine. Epidemiology requires 
some of the skills of clinical diagnoses together with the 
use of statistics.
In clinical practice, the decision making is usually 
dichotomous, patients either have or do not have a disorder, 
and either are or are not treated. In hospital practice this 
is often relatively easy, as borderline cases tend not to be 
referred to hospital. Thus the distribution of a rating 
scale for dementia in a psychiatric ward is likely to be 
bimodal, one mode corresponding to those admitted for 
dementia and one to those who were not.
89
However within the general population rating scales for 
mental illness shows a continuous unimodal distribution. 
Therefore within a community population the appropriate 
question may be not 'has he got it?' but 'how much of it has 
he got?'. If attention is confined to severe and therefore 
obvious cases, then epidemiology will be less likely to 
fulfil its potential to answer questions of causation. 
Epidemiology has the potential for understanding and 
therefore perhaps controlling, the mass determinants of 
population means, prevalence rates and incidence rates of 
illness and merges into social research and social policy 
(Rose 1989).
The epidemiologist does not investigate the patient who has 
presented with symptoms, but instead investigates a total 
population, most of whom may be well, and some who may have 
unrecognised pathology. As consultation is not patient 
initiated, epidemiologists must also be aware of, and 
concerned, about the purpose and ethics of investigations. 
These will be discussed further in section 5.3.
The most commonly used methods of epidemiological enquiry are 
the cross-sectional survey, which can be a one or two phase 
method; the case control study and the longitudinal study 
(see below). The epidemiological description of a disease 
is derived from relating the characteristics of a group of
90
cases, such as age and sex, to those of the population in 
which they belong. These characteristics of the population 
base are discussed in chapter 6, section 2.
5.2b. THE CROSS-SECTIONAL SURVEY.
The cross-sectional survey consists of examining a complete 
defined population for the conditions of interest. There are 
three aims of cross-sectional surveys,
(1) description of a disease in the community and its 
distribution
(2) study of the causes of disease
(3) screening for hitherto undiagnosed cases (Barker & 
Rose 1984).
The cross-sectional survey is an appropriate tool for chronic 
conditions such as schizophrenia or dementia, but as the 
probability of detecting a case of disease is related to the 
disease's mean duration, it is inappropriate for acute 
conditions such as infectious diseases. In the two phase 
cross-sectional method, the first phase is a case finding 
screen and the second phase defines and describes the cases 
in more detail.
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5.2c. THE CASE CONTROL STUDY
The case control method matches cases to non-cases 
(controls). The method is reviewed by Lewis & Pelosi (1990). 
It is usually concerned with aetiological questions, and 
identifies differences in exposure between cases and non­
cases. It is especially useful in rare conditions, when very 
few cases may be picked up by surveying whole populations. 
The difficulty with this method is selecting appropriate 
controls, who have to be matched for variables associated 
with the development of the disease, from the aetiological 
and social factors being studied. Statistical tests of 
significance estimate the probability of any association 
between exposure and disease being by chance. Reverse 
causality can occur when the disease may cause the exposure, 
for example in the debate about whether unemployment causes 
ill health, or ill health unemployment. Another mistake that 
can occur is when an independent risk factor (a confounding 
factor) is present in association with the exposure. This 
can lead to a spurious association, or can eliminate a real 
association.
5.2d. THE LONGITUDINAL STUDY.
Finally the longitudinal study can either follow a population
92
prospectively to determine risk factors and incidence, or 
follow early cases to determine natural history, and outcome, 
or compare the association between initial characteristics 
and the risk of future disease. One type of longitudinal 
study is a cohort study which is designed to test a specific 
aetiologically hypothesis. The difference between a case 
control and a longitudinal cohort study can be seen, for 
example, in the case of rubella and its association with 
congenital cataract. A case control study would compare 
people with a congenital cataract and a matched control group 
without, for example a history of maternal rubella, thus 
confirming the aetiological importance of rubella. A cohort 
study of rubella in pregnancy might follow up mothers who had 
developed rubella during pregnancy and the children born to 
them, and thus quantifying the risk associated with rubella.
5.3. SCREENING.
Once it is known how to recognise a particular disease before 
the patient may present spontaneously to doctors, the 
questions, whether to screen and who to screen for the 
disease throughout the at risk population arises. Sometimes 
only those at high risk are screened, this is known as 
targeting. Alternatively, opportunistic screening may take 
place when the screening procedure is part of a consultation
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initiated for other reasons. These two procedures are 
cheaper than screening the whole population but cases may be 
missed.
Wilson & Jungner (1968) reviewed the ten principles of 
screening. These are: 1) that the disease should constitute
an important public health problem 2) that there should be an 
accepted form of treatment for those persons having the 
disease once recognised 3) facilities for diagnosis and 
treatment should be available to the population in question
4) there should be general agreement among clinicians as 
regards the indication for treatment 5) the natural history 
of the condition should be adequately understood 6) there 
should be a recognisable latent or early symptomatic stage of 
the disease 7) a suitable test should be available 8) the 
screening method should be acceptable 9) the cost of case 
finding should not be excessive in relation to other existing 
health service priorities and 10) the screening programme 
should provide a basis for a continuing process of early 
detection.
They comment that these requirements now command broad 
acceptance in the field of preventative and social medicine. 
Using these principles in the United Kingdom, for example, 
cervical cancer screening is currently available to all 
women, and screening for anaemia, renal impairment and
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syphilis is automatically carried out in antenatal care, 
because pregnant women are at high risk of anaemia and renal 
impairment and because, in the case of syphilis, the 
detection is easy and sensitive and congenital syphilis is 
a serious disease with effective and acceptable prophylaxis.
The debate over the purpose and ethics of screening the 
asymptomatic population has been intensified by the emergence 
of the autoimmune deficiency syndrome (AIDS) and the 
screening test now available for the human immunodeficiency 
virus (HIV). It is now generally agreed that HIV testing, 
unlike other screening procedures, requires both written 
informed consent and counselling prior to testing. In 
contrast in pregnancy, consent for testing is assumed. In 
HIV, the ethical dilemma lies in informing people who may be 
asymptomatic, that they had a virus which might lead to a 
fatal illness and for which until recently there was no 
treatment at either the asymptomatic or latent stage. This 
and the fact that the natural history of AIDS was not well 
understood went against the accepted principles of screening. 
However many people who felt that they might have been 
infected by HIV, wanted to know their status for the purposes 
of planning and controlling their lives. Counselling gives 
people the knowledge to enable them to make an informed 
choice as to whether to be tested or not. Recently, 
literature on the psychological costs of screening reports
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high levels of anxiety in patients participating in screening 
programmes which are not always allayed by negative results. 
Conversely, others overgenerate a negative result, and this 
reinforces an unhealthy lifestyle. Increased knowledge of 
the reasons for screening the particular patient, the meaning 
of results and how the patient can reduce risks, all help 
allay anxiety (Marteau 1990).
The principles of screening have developed over the nineteen 
eighties. A new formulation might now be that if principles 
two to five are not applicable then counselling should be 
mandatory prior to screening.
5.4 RELIABILITY AND VALIDITY OF SCREENING INSTRUMENTS
Once a decision to screen has been made, any epidemiological 
studies require the use of screening procedures which must 
be reliable and valid. The concepts of reliability and 
validity are reviewed by Goldberg (1989) and Barker & Rose 
(1984) and are discussed in the remainder of this section. 
The practicalities of choosing a screening instrument are 
reviewed in chapter 6.5.
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5.5 RELIABILITY
Reliability concerns the repeatability of a measurement. It 
is influenced by within-subject variability, and observer 
(measurement) variation. Intra-observer variation is random 
and occurs between observations of the one observer, made at 
different times. In contrast inter-observer variation can 
be decreased by training and is usually systematic, so that 
different raters can be trained to agree on how to classify 
a symptom or sign. This interrater reliability should be 
measured when survey instruments are developed, to ensure 
that the instrument is capable of being used consistently. 
In individual surveys, interrater reliability can be measured 
again, to ensure that raters are recording consistently.
Within subject variability is usually random and therefore 
on average cancel out in population studies and so will not 
be important. However inter temporal reliability, that is 
stability of categorization over time, is also related to 
what is being measured. For example a schedule rating short 
term illness would not be expected to show temporal 
stability.
5.6 VALIDITY
The ideal screening test would correctly classify all people
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as either having or not having the condition in question. 
As the ideal measure does not usually exist and the question 
is often "how much" not "if", the validity of an instrument? 
the ability to measure what it is designed for, gives a 
numerical value to the accuracy of the instrument. Validity 
can be divided into four types. These are sensitivity, 
specificity, concurrent validity and predictive validity.
Sensitive tests correctly identify cases. The sensitivity 
of a test equals the true positives found expressed as a 
percentage of the number of true cases. Conversely a 
specific test will not misclassify normals as cases. The 
specificity of a test is the true negatives expressed as a 
percentage of the non-cases.
The concurrent validity measures the ability of a test to 
respond to the severity of the disorder rather than to 
classify it only as present or absent. It is usually 
measured by a rank-order correlation coefficient, between 
scores on the instrument and total severity scores on some 
standardised research interview.
The predictive validity is the ability of an instrument to 
classify as cases those who have an outcome on follow-up 
consistent with that expected of cases.
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Three other measures of validity of a screening procedure are 
sometimes quoted. These are the positive predictive value 
(PPV), which is the probability that an individual case found 
on the instrument used will be found to be a case on future 
examination, the negative predictive value (NPV) which is the 
probability that a 'non-case' found on the instrument will 
be found to be a non-case on future examination, and the 
other overall misclassification rate (OMR) which refers to 
the percentage of misclassified cases. All are dependent on 
prevalence. Therefore when the prevalence rate of a 
condition is low the positive predictive value will decrease.
The concept of reliability and validity assume some absolute 
standard which can confirm the results of the screening 
instrument. As already discussed, most psychiatric diagnoses 
are not dichotomous but a question of spectrum diagnoses. 
Therefore it is important that validation is regarded as only 
confirming that an instrument can, to a specified degree, 
answer a specific question in a given population.
Having now discussed the theoretical issues related to 
screening for the dementias, the next two chapters will 
discuss the setting up of a community screening study for the 
dementias and published studies.
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CHAPTER 6
SETTING UP A COMMUNITY SURVEY OF DEMENTIA IN THF. ET.DERLY
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6.1 INTRODUCTION
Before a community survey can be undertaken a population must 
be defined and identified (a population register). Then 
appropriate tools must be employed to answer the questions 
posed.
Ideally a population register should contain every person 
within the population meeting the study criteria. Every 
person on this register should be interviewed by trained 
interviewers using a method of detection which identifies 
cases without error. The whole project should be acceptable 
and economic in the population studied. As these ideals are 
not achievable, many different methods have been tried to try 
to attain an ideal survey.
6.2. CHOOSING THE POPULATION BASE
The practical task of enumerating the population for study 
has been tackled in a number of different ways.
a. General Practitioners' Lists
The most common source in the UK has been the general 
practitioners or Family Practitioner Committee list (Clarke 
et al 1986, Morgan et al 1987, Copeland et al 1987a, Copeland
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et al 1987b, Brayne & Calloway 1989, O'Connor et al 1989). 
However populations are mobile so these lists become quickly 
out of date. For example recently nearly 25% of people in 
Liverpool lists were found to be dead or have moved away 
(Copeland et al. 1987), while in a London study, 35% of women 
did not receive letters posted to them because of 
inaccuracies in the Family Practitioner Committee's database 
(McEwan et al. 1989). Older people within the area studied 
may not be on any of the local General Practitioners' lists 
but may consult a General Practitioner some miles away, or 
be on the list of a private practice. Brayne & Calloway 
(1989) in rural Cambridgeshire state that they have 
surmounted difficulties in listing the population, by 
studying a highly stable group, which is served by one single 
health centre with virtually no cross boundary flow. However 
they do not cite any procedure used to validate the General 
Practitioners' lists they employed.
b. Patients using services
Alternative sources for obtaining a base population have been 
patients attending a health centre and any friend or relative 
accompanying them (Griffiths et al. 1987), or patients from 
the mental health services (ten Horn, 1985). However, as 
those in contact with health professions are always selected, 
elderly populations from these sources must be an inaccurate 
basis for a study.
102
c. The electoral roll
The electoral roll has also been used as a basis for sampling 
(Kay et al. 1964, Cooper & Bickel, 1984, Mowry & Burvill, 
1988, Lindesay et al 1989). In Britain the electoral roll 
is not fully satisfactory, as there is no compulsory 
registration and the voter's age is not recorded. British 
surveys using the electoral roll have therefore required to 
contact each individual regarding their age or date of birth, 
and follow up the non-responders (Kay et al 1985, Lindesay 
et al 1989). To support the use of the electoral roll, one 
study checked if those patients diagnosed as demented by the 
local psychiatric services were included in the electoral 
register (Lindesay et al 1989). They discovered 94% were on 
the register. However this validation exercise is still 
unsatisfactory as it is not known whether those referred to 
psychiatric services with dementia are the same as those who 
are not. It may be that the same people are neither known 
to psychiatric services, nor are on the electoral register.
d. State Lists
Certain countries have a list of all elderly in a particular 
locality. These lists can be used as a sampling frame. For 
example in New York a list was used from the State Office for 
Ageing (Gurland et al. 1983). Similarly in China a list from 
the residents committee in Beijing is available (Li et al. 
1989), as is the district register in South Africa (Elk et 
al. 1983). In Britain there is no such list available.
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e. Visiting every house
The only other method which remains is to visit every 
inhabited dwelling. This laborious method was undertaken in 
Mississippi for a whole county (Schoenberg, 1985).
6.3. DEMOGRAPHY OF THE POPULATION BASE
The variables to be defined in the target group can be 
divided into the personal, that is the age group, sex and 
race; and into the definition of the community, that is 
whether institutions should be included or not, and whether 
urban or rural areas should be surveyed.
AGE OF THE POPULATION
The first UK community survey of dementia targeted 
exclusively those over 65 years of age (Kay et al. 1964); a 
decision which some later studies have followed (Morgan et 
al. 1987, Lindesay et al. 1989). Others have argued that as 
dementia is more prevalent in the more elderly, it makes more 
sense to restrict the study to an older age group and they 
have studied the over 70s (Kay et al. 1985, Mowry & Burvill,
1988), the over 75s (Clarke et al. 1986, O'Connor et al.
1989) or the 70-79 year age group (Brayne & Calloway, 1989). 
The younger elderly, the over 60s are the subjects in other 
surveys (Griffiths et al. 1987, Li et al. 1989). Finally 
some papers have described the prevalence of dementia 
throughout all age groups (Schoenberg et al. 1985, Folstein
104
et al. 1985). As the prevalence of dementia increases with 
age, the resulting overall prevalence rate will be greatly 
affected by the age groups which are surveyed.
SEX OP THE POPULATION
Most surveys have interviewed both men and women. Sayetta 
(1986) set a precedent by interviewing only men. Brayne & 
Calloway (1989) decided to interview only women, because a 
study "conducted on both sexes over an unlimited age range 
would have produced small numbers in some age groups and 
consequently little confidence in the distribution".
RACE OF THE POPULATION
Although usually the whole population is of interest, some 
studies have been specifically concerned with the differences 
between races (Schoenberg et al. 1985), or with one racial 
group, such as the coloured in Cape Town (Ben-Arie et al.
1983).
6.4. THE COMMUNITY.
The definition of the community is vague. According to the 
Shorter Oxford English Dictionary (1973), it is 'a body of
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people organised into a political, municipal or social 
unity'. This has been taken by some workers to mean all 
those living in their own homes (Kay et al. 1985, Schoenberg 
et al. 1985, Morgan et al. 1987, Mowry & Burvill, 1988), 
while others have included hospital and social service 
institutions (Kay et al. 1964, Brayne & Calloway, 1989). As 
in Britain around 5% of the elderly, who are usually the most 
disabled elderly, live in institutions, prevalence figures 
will significantly change according to which definition is 
used.
Most recent studies have concentrated on urban environments, 
for example Liverpool and London, but the rural elderly have 
been studied in the UK (Griffiths et al. 1987, Brayne & 
Calloway, 1989), and in Japan (Shibayama et al. 1986). These 
surveys suggest that, for an unknown reason, prevalence 
figures for dementia may be lower in a rural, as opposed to 
urban environment but more data are still required.
6.5. CHOOSING THE METHOD OF ASSESSMENT (SCREENING)
A recent paper pointed out that cases are in fact concepts. 
"They exist only in the mind of the investigators and are not 
to be sought like precious stones, but should be defined as 
need dictates and then sorted according to these criteria". 
(Copeland, 1990). The remainder of this section is partially 
concerned with whether investigations have borne this in mind
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when choosing assessment instruments.
As dementia is not usually accompanied by insight, self 
report has not been used as a method of assessment. 
Therefore methods of case ascertainment have been varied and 
seem to have been chosen according to composition of the 
survey group. They include;
(i) diagnosis by a psychiatrist.
(ii) a questionnaire - content not specified.
(iii) standardised brief screening tests for cognitive
function.
(iv) semi-structured standard interview for the elderly.
(v) a combination of the above.
Psychiatrists' Assessment:
1) In Newcastle, psychiatrists made a clinical diagnosis 
according to broad diagnostic criteria (Kay et al. 1964). 
This approach is an expensive one, requiring 
psychiatrists to make diagnoses on every survey subject. 
In the above study diagnostic criteria are not specified 
or standardised, so it has been difficult to compare with 
other studies.
Questionnaire:
2) Schoenberg et al (1985) in Mississippi, and Shibayama et 
al (1986) in Japan used questionnaires administered by 
trained interviewers. Although training of the
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interviewers itself builds in some measure of 
reliability, no validation of the interview was reported.
Brief assessment procedures:
3) Brief assessment procedures for intellectual screening 
are more satisfactory. They are usually standardised, 
reliable and validated. However the standards that they 
are validated against are not designed to eliminate other 
illnesses which might mimic dementia, for example 
depression. In addition they may be validated against 
a standard which is not suitable for community surveys. 
For example the Clifton Assessment Schedule which was 
used in Melton Mowbray and Nottingham (Clarke et al. 
1984, Morgan et al. 1987) was developed for use in
institutions. It therefore has been found not to 
identify those with a mild dementia (Brayne & Calloway,
1989), suggesting that prevalence figures based on this 
test would be underestimated.
THE MINI MENTAL STATE EXAMINATION
The Mini Mental State Examination (Folstein et al 1975) 
has been used for screening in Baltimore, Canberra, 
Cambridge, Beijing and London (Folstein et al. 1985, Kay 
et al. 1985, O'Connor et al 1989a, Li et al 1989, and 
Iliffe et al 1990), or as part of a semi-structured
interview in Cambridge (Brayne & Calloway, 1989) and
South Africa (Ben Arie et al. 1983). A particular
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difficulty has arisen with the Mini Mental State (MMSE) 
which has different versions which are not all equivalent 
(Kay et al. 1985, Mowry & Burvill, 1988, Brayne & 
Calloway, 1989), as some surveys do not state which 
version is used. In addition, as the scores have been 
shown to vary with level of education of the respondent, 
different cut points are used in different populations 
eg in China <17 or in Baltimore <23. In South Africa the 
best cutoff point for the population is not known as the 
MMSE had not been standardised there. Thus all subjects 
'screened' with the MMSE had to be re-examined by two 
independent psychiatrists.
Within the UK, Brayne & Calloway found that using a cut 
point of 21/22 on one version of the Mini Mental State, 
gave a sensitivity of 83% and a specificity of 87%. This 
sensitivity is too low if the purpose of screening is to 
find all causes of dementia either for research or 
service planning. O'Connor et al (1989), who used the 
MMSE as a screening instrument with the Camdex as 
validation, found that 13% of those who scored as high 
as 24 or 25 on the MMSE, regarded in some studies as in 
the normal range, had a diagnosis of dementia, but only 
55% below the cutoff point were judged to have an organic 
disorder. Further there were 13 people in the area 
surveyed who were known by the services to be suffering 
from dementia but who had been missed altogether in the 
study. They concluded that the MMSE "cannot be used to
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make even tentative psychiatric diagnoses" (O'Connor et 
al 1989b). It is therefore not established which cut 
point should be used even within the UK, when the Mini 
Mental State is used for screening, so that accurate 
figures for the prevalence of dementia can be attained.
(4) Semi-structured standard interviews for the elderly are 
tests which collect cognitive data in the setting of a 
more extensive mental state examination. The three 
interviews which are used are the Comprehensive 
Assessment and Referral Evaluation (CARE), the Geriatric 
Mental State (GMS) and the Cambridge Mental Disorders of 
the Elderly Examination (CAMDEX).
THE CARE
The CARE (Gurland et al 1984) has been used in the US/UK 
cross national study, in Canberra and London (Gurland et al. 
1983, Kay et al. 1985 and Lindesay et al, 1989). The short- 
CARE was developed from the CARE, as the length of CARE is 
prohibitive for use as a screening procedure. While the CARE 
consisted of 1,500 items and 22 indicator scales, the short- 
CARE consists of 6 of the 22 indicator scales. With 
reference to the detection of dementia the short-CARE 
contains a screening scale, namely the organic brain syndrome 
scale (OBS) and a diagnostic scale, namely the dementia 
diagnostic scale (DDS). The OBS was designed as a
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sensitive indicator scale for cognitive impairment, the DDS
to detect probable cases of pervasive dementia which are
severe enough for clinical intervention (Kay et al 1985). 
The OBS consists only of cognitive items, and the DDS of 
cognitive items linked with items indicating incapacity, from 
an activity of daily living scale. As with the MMSE,
different cut points can be used for different studies. For 
example on the OBS scale the validated cut point is >4. 
Lindesay et al (1989) study analyzed the data using two cut 
points of >3 and >6. These cut points were used to give a 
"broad" and "narrow" definition of cognitive impairment. 
Other studies use the DDS scale, which generates diagnosis 
of dementia as a basis for prevalence figures. The
limitations with the short-CARE are firstly, the absence of 
a history incorporated in the short-CARE, so that the short- 
CARE is suitable only as a screening instrument identifying 
probable dementia, and not adequate to give a precise 
diagnosis, despite the scale called the Dementia Diagnostic 
Scale. Secondly, different cut points make comparison 
between studies difficult. One of the strengths of the CARE 
is that it allows the rater to score failure to answer as 
pathological. For example, for the question, "how old are 
you", the questionnaire allows either "states does not know 
or does not complete the answer" or "stated age different 
from the most accurate estimate" as pathological.
The CARE is a validated and reliable instrument. The inter­
rater reliability of the dementia scale is .75 (Gurland et
111
al 1984) and a follow up study has been validated by a one 
year study which showed outcomes consistent with that 
expected of clinical dementia in all cases (Gurland et al
1984). However these advantages are lost when a non­
standardised cut point is used, as happened recently in a 
London inner city population, similar to the population in 
which the CARE was first validated (Lindesay et al 1989).
GERIATRIC MENTAL STATE
The full CARE was developed from the Geriatric Mental State 
and is therefore similar (Copeland et al 1976). Algorithms 
have now been developed for a computerised diagnostic system 
for use in the community: GMS(A )/AGECAT (Geriatric Mental
State (A)/Automated Geriatric Examination for Computer 
Assisted Taxonomy (Copeland et al 1986)). The GMS is a semi­
structured clinical interview designed to record patients' 
current cognitive state and their mental state during the 
month prior to interview. Individual symptoms are rated in 
eight sections covering major syndromes (Gurland et al 1976). 
Although patients can score on all eight of the symptom 
clusters they are ultimately allowed only one diagnosis. The 
GMS (A) is a shortened version of the GMS which has been 
developed for use in the community, by analysis of data sets, 
to remove questions which are less relevant for a study 
population out of hospital (Copeland and Wilson 1989). The 
AGECAT programme ensures that patients with the same symptoms
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are rated as having the same syndromes and given the same 
diagnosis on each occasion.
The strengths of the GMS are that it allows for a wide number 
of diagnoses, which should decrease the number of false 
positive diagnoses, and that its standardised programme means 
that different studies are directly comparable as 
investigators are not able to change diagnostic criteria. 
The GMS has been used in prevalence surveys without the 
AGECAT programme in Hobart, Australia and latterly with 
computerised diagnoses in Liverpool (Kay et al. 1985, 
Copeland et al. 1987). In published prevalence studies, the 
GMS did not have available an accompanying section collecting 
historical data. However now this is available and this 
measure can potentially be used for both screening and for 
diagnosis at the same interview.
The GMS has weaknesses, when used in prevalence studies. 
Firstly on the organic scale there is no assessment of 
activities of daily living, therefore the diagnosis generated 
by AGECAT cannot include the criterion of functional 
deterioration. Secondly, replies are only rated as 
pathological if they are wrong or the patient states that he 
does not know the answer. If the patient does not answer 
this does not score as pathological. However in the latest 
version GMSA (3) this scoring has been changed and as in the 
case of the short-CARE, irrelevant or incomplete replies to 
cognitive questions are also rated as pathological. Thirdly,
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patients are only allowed one diagnosis despite the known 
occurrence of, for example dementia and depression together.
Copeland et al (1976) reported two studies of interrater 
reliability in rating the GMSA. In the first study agreement 
on principal diagnostic categories is 95%. The correlation 
coefficient for positive rating is 0.87. The second study 
which compared reliability on the GMS of raters from the USA, 
with each other, and raters from the UK with each other, 
resulted in a correlation coefficient of 0.72 in the UK and 
0.71 in the USA.
After the introduction of AGECAT, the diagnostic validity was 
measured as the concordance rate between AGECAT and 
psychiatrists' diagnoses. The correlation coefficients were 
0.84 in a psychiatric hospital setting, and 0.74 in a 
community setting (Copeland et al 1986).
THE CAMDEX
The semi-structured instrument, the CAMDEX (Roth et al 1986) 
consists of a neuropsychological battery (CAMCOG), a mental 
state examination, an informant interview, a physical 
examination and optional laboratory investigations.
Roth et al (1986) reported an interrater reliability study 
of the CAMDEX using inpatients and outpatients in Cambridge. 
Two psychiatrists interviewed patients using the CAMDEX as
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an interview instrument, then made a diagnosis. There was 
complete agreement on cases diagnosed by the two 
psychiatrists as either normal or dementia. However the 
Kappa coefficient for diagnostic agreement was reduced to 
0.63 when dementia was subdivided into Alzheimer's Disease, 
multi-infarct dementia, mixed dementia and secondary 
dementia. Sensitivity and specificity was measured using 
either the MMSE as a screening instrument or the Cambridge 
cognitive examination (CAMCOG) section of the CAMDEX. 
Sensitivity for the MMSE was 94% and specificity 85% using 
the optimal cutoff of 23/24. Sensitivity of the CAMCOG was 
92% and specificity 96%.
The CAMDEX was used by Brayne & Calloway (1989) as a 
diagnostic instrument. All subjects were interviewed in 
depth without prior screening. The CAMDEX requires a doctor 
with specific training in its use to administer it, and takes 
on average nearly two hours per subject. This makes it a 
very expensive screening instrument. Nevertheless Brayne
interviewed 365 elderly people using the Camdex. However as 
there are no other prevalence screening studies which have 
used the CAMDEX, it is not possible therefore to compare the 
prevalence rates published from the use of the CAMDEX 
directly with other studies.
This chapter has so far discussed the theory of setting up 
a community survey of dementia in the elderly. The next 
sections discuss the results of studies which have been
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reported in the last four years; how the methods used have 
affected the findings and the ideal study.
6.6 RECENT RESULTS OF PREVALENCE SCREENING FOR DEMENTIA 
(PHASE I STUDIES)
The smallest overall prevalence of dementia in the over 65s 
(3.2%) comes from a survey using the CAPE, which is designed 
for use in hospital (Morgan et al 1987), and from a survey 
using the narrow diagnostic scale from the CARE, the DDS 
(2.3%) (Copeland et al 1987). Analysis of the same 
interviews using the GMS/Agecat increases the figures to 
4.3%.
Studies published in the last four years are summarised in 
tables 4 and 5.
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Phase I screening studies for dementia published between 
1987 and 1990 show an increase prevalence of dementia with 
age and in females. This is not necessarily because of a 
true excess of dementia in women; the longer survival of 
women may lead to a higher prevalence of dementia in 
women.
This was first suggested by Tomlinson et al (1964) because 
of the excess of male deaths in their postmortem series. 
Later, Blessed & Wilson (1982) in their follow-up of 
patients with dementia noted longer survival of women with 
senile dementia. To date the data concerning the 
incidence of dementia has not been established so it is 
not known if the longer survival of women with dementia 
accounts for the excess of women.
The prevalence of dementia in the over 65 year old age 
group is somewhere between 2.3% and 10.1%. It is 
impossible to say whether these various figures reflect 
only methodological differences or true differences within 
populations.
6.7. RESPONSE RATES IN SCREENING SURVEYS.
Response rates in screening surveys vary enormously. 
Studies in the last 5 years have reported rates varying 
from 97% in Mississippi (Schoenberg et al. 1985) to 72% in 
Liverpool (Copeland et al. 1987). Schoenberg's study was 
the only study in which enumeration took place by door
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knocking contact. Interviewing was carried out at the 
same time as enumeration, thus this appears to be the best 
method of gathering as complete a sample as possible. 
However the next most complete sample which achieved a 91% 
interview rate (Brayne & Calloway, 1989) had exactly the 
same methodology as in Liverpool. Letters were sent from 
the General Practitioner requesting interview, and non­
respondents to these letters were visited personally at 
home. Cooper and Bickel (1983) had previously concluded 
from a literature review that the best way to gain a high 
response rate was for an invitation to come from the 
physician or other health professional whom the family 
already knew. It is unclear why there is this discrepancy 
in response rates using similar methods, but it may be 
that the higher inner city crime rates in the UK, make 
pensioners less willing to allow interviewers in their 
home than in rural Cambridgeshire. It may also be that an 
interviewer who is both a doctor and female is more likely 
to be allowed access than other interviewers.
It is important that those who do not respond to interview 
invitation are visited at home, as it may be that those 
who do not answer letters are different from those who do, 
particularly in terms of cognitive ability. This question 
has not been directly addressed, although Jorm et al. 
(1987) in his review of prevalence surveys concluded that 
differences in response rates did not materially affect 
prevalence rates.
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6.8 CONCLUSIONS
THE IDEAL STUDY
In conclusion the ideal study to determine the prevalence 
of the different types of the dementias has never been 
reported. This study would entail a community screening, 
from a population list compiled either by door knocking or 
by using General Practice lists either in an isolated area 
where there is no cross boundary drift or in areas where 
all general practice lists can be included. A screening 
instrument would be used which was known to be reliable 
and valid within the population studied. Both men and 
women would be screened as it is not known whether the 
prevalence is the same in both sexes. A high response 
rate would be achieved either by interviewing while 
enumerating, or by sending a letter from the general 
practitioner to request interview, followed by personal 
visits to non-responders.
There are at present no studies which completely fulfil 
these criteria. The best studies were those of Brayne and 
Calloway's (1989) which screens 91% of a total population, 
enumerated from general practitioner lists but interviews 
only women using an non-validated list; Schoenberg et al's
(1985) study which screens 97% of a population enumerated 
by door knocking but does not use a validated instrument, 
and Gurland et al's (1983) US study which screens a
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population from a list held by the State Office of Ageing 
using a semistructured instrument but achieves a response 
rate of only 71%.
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CHAPTER 7
THE PHASE II STUDY - DIAGNOSTIC STAGE
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7.1. CHOOSING THE METHOD OF ASSESSMENT (PHASE 2
STUDIES)
Five phase 2 studies in which the people who were 
identified as organic or dementia cases in a community 
sample are re-interviewed have been reported. The methods 
used for Phase II are either diagnosis by a doctor in 
accordance with published criteria (Folstein et al 1985, 
Li et al 1989, Shibayama et al 1986), or the use of the 
Camdex as a diagnostic instrument (Brayne and Calloway 
1990, O'Connor et al 1990).
These studies were:-
1) The NIMH Diagnostic Interview Scale (DIS)
which the Mini Mental State Examination 
incorporated as the organic screen. All subjects 
identified as having probable dementia and 17% of 
those without a diagnosis were then examined by 
a psychiatrist who made standardised clinical 
diagnoses according to the criteria of the 
Diagnostic and Statistical Manual, Third edition 
(DSM III). In a third phase all subjects 
diagnosed by a psychiatrist as having a definite 
or possible dementia syndrome were recruited for 
a clinical and laboratory workup, and medical 
records were reviewed (Folstein et al. 1985).
2) The Camdex was used in a combined two phase study
in rural Cambridgeshire (Brayne & Calloway, 
1989).
in
is
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A phase I screening used the MMSE. Phase II 
interviewed all those who scored 23 or below on 
the MMSE, and one in three who scored 24 or 25. 
Camdex was then used as a phase II instrument 
(O'Connor et al. 1989a) . The two Camdex phase 
results are not directly comparable as Brayne & 
Calloway included minimal dementia, which was 
excluded by O'Connor et al. and Brayne & 
Calloway unlike O'Connor et al performed 
laboratory tests.
In Beijing, initial screening of subjects was 
performed, using the Mini-Mental State (cut off 
<17). All suspected cases of dementia and 5.5% 
of all others were then seen for a full clinical 
examination. Subjects were diagnosed and 
classified according to DSM-III criteria (Li et 
al 1989).
In Nagoya, Japan, trained interviewers obtained 
details of health states, social and domestic 
data. People suspected of dementia by a 
psychiatrist on the basis of this interview were 
re-interviewed, and had a neurological 
examination. Diagnostic criteria and
definitions were in accord with DSM-III with 
reference to ICD-9 and Hachinski's Ischaemic 
Score (Shibayama et al 1986).
7.2. RESPONSE RATES IN PHASE II STUDIES.
As might be expected the response rates in a phase II 
studies may also be less than 100%, resulting in a further 
loss of information. Folstein et al (1985) reported a 78% 
completion rate for phase I of his Eastern Baltimore 
service. 75% of those subjects who had a positive
screening test completed phase II, 82% of whom agreed to
the phase III procedure. However, a diagnosis could be 
made on the remaining 18%. O'Connor et al (1989) report 
a response rate in the first part of the study of 90%, 
with 82% of these agreeing to phase II of the study. In 
Beijing 82% took part in the first interview. All 42 
patients who scored as cases were re-interviewed.
Similarly Brayne and Calloway did not lose any subjects as 
their study combined phase I and II interviews. No 
information is given on response to phase I in Japan, 80% 
of the first phase cases were re-interviewed.
7.3. THE PREVALENCE OF THE SUBCLASSIFICATIONS OF
DEMENTIA IN THE POPULATION (PHASE II STUDIES).
Marsden and Harrison (1972) in their study of the 
differential diagnosis of 106 patients under 65 referred 
to a neurological hospital with presumptive dementia found 
that 45% had presumed Alzheimer's Disease, 7.5% had
arteriosclerotic dementia, 7.1% had a space occupying
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lesion, 5.7% had an alcohol related cause. No other cause 
of dementia contributed more than 5% of cases. A total of 
15% of their patients had a condition potentially amenable 
to treatment and 15% were judged not to be demented. This 
interesting finding led to a proliferation of studies, so 
that Clarfield (1988) found thirty-two studies, with a 
total of 2889 subjects in all, which investigated the 
prevalence of the different causes of dementia in clinical 
series of patients. In this overview, Alzheimer's Disease 
made up 56.8% of all dementias, multi-infarct dementia 
13.3%, depression 4.5%, alcohol 4.2% and medications 1.5%. 
No single other cause contributed more than 1.6% of the 
cases. Potentially reversible causes made up 13% of all 
cases. The commonest reversible causes were medication
(28%), depression (26%) and metabolic diseases (15.5%). 
Eleven studies provided follow-up data and in those 8% of 
the dementias had resolved partially and 3% fully. 
However there are certain biases in the studies that 
contribute to the review.
These are:-
1) A low mean age in the studies. Alzheimer's Disease 
manifests itself particularly in the over 75s, but the 
mean age of the patients in these studies was 72 
years. Those studies which followed up patients with 
potentially reversible dementias had a mean age of 62. 
This age effect would imply that there would be less 
Alzheimer's Disease and more other causes of dementia
127
than in an older population.
2) Only four studies originated from the community.
Selection for referral may mean that those with an 
atypical dementia are more likely to be seen by
hospital doctors.
Clarfield compares this situation to that which occurred 
in hypertension. "Physicians thought they were faced with 
a high prevalence of a devastating condition, a 
significant proportion of which might be potentially
reversible. It followed that there might be many
potentially curable conditions obscured by the mass of
essential hypertensive patients. Based on early figures 
from tertiary referral centres of 6% for 'surgically 
curable hypertension' a vigorous, costly and sometimes 
dangerous investigation was recommended and done on many 
patients, most of whom did not turn out to have a 
reversible disease. With time it became apparent that the 
true prevalence of reversible hypertension in the 
community was probably less than 1%". More accurate 
figures on the prevalence of the different dementias may 
be found by analyzing the community studies separately. 
Since Clarfield's review, 4 further studies have been 
published on the prevalence of the different dementias. 
The eight community studies are shown in Table 6. Only 
five of those incorporate a phase I screen of a community 
(see 7.1).
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The first community study of the patterns of the dementias 
was performed by a neurologist, retrospectively reviewing 
all medical records of Rochester residents (USA) (Kokmen 
et al 1980). Subjects had to have documented evidence of 
dementia presenting to medical attention. As many 
subjects with dementia are unknown to physicians this 
method does not ensure accurate numbers (Williamson et al 
1964, O'Connor et al 1988). Folstein et al (1985) report 
differential diagnosis of cognitive impairment in the 
population of Eastern Baltimore using the MMSE. This 
study suffered from the limitations of the Mini Mental 
State as a screening interview, and from a fall out rate, 
at each of the three phases, of 20-25% of subjects. This 
meant that at the end a diagnosis was only made on 36 
subjects. These diagnoses, made on DSM III criteria, were 
divided only into either Alzheimer's disease, multi­
infarct dementia, mixed, or unspecified dementia. However 
Folstein comments that no reversible dementias were found.
Sayetta et al's (1985) study was a longitudinal study of 
male volunteers. This unrepresentative sample makes it 
difficult to interpret the results. Similarly Pfeffer et 
al (1987) study was of a middle class retirement 
community. This unusual community, together with a rate 
of cognitive screening of less than 60%, makes the 
representativeness of the results questionable. This 
impression is reinforced by the very high prevalence of 
dementia found (16.4%) for those aged over 65. This
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figure is much higher than other American studies.
In China, Li et al (1989) only found 14 cases of dementia 
to classify. They do not specify the criteria for the 
eventual diagnoses. The other limitation of this study is 
the lack of validation of the screening instruments in the 
Chinese population.
The British studies (O'Connor et al 1989, Brayne & 
Calloway 1989) were of larger populations. O'Connor et 
al screened in Cambridge, using GP lists as a population 
register. No check of the accuracy of GP lists on which 
the sample was based was carried out. Surprisingly, the 
screening and diagnostic phase missed 13 patients known to 
the services and well documented as demented. These were 
added to the numbers thus perhaps skewing the results, and 
calling into question the sensitivity of the instruments 
used. No laboratory investigations were performed, thus 
cases of secondary dementia may have been missed. 
Nevertheless, this study was the first published attempt 
to carry out a full diagnostic study of dementia in the 
elderly by screening and follow up.
Brayne & Calloway's study is limited by the exclusion of 
men and the relatively small numbers. However, unlike 
O'Connor et al, they comment on the validity of their 
original sample, although they do not test their 
hypothesis, that people will not be lost to GP lists in a
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country area such as theirs. They classify subjects only 
into four categories? SDAT, MID, SDAT plus MID and others.
The final study shown in Table 6 (Shibayama et al 1986) 
suffers from using a non-validated screening instrument.
Overall of the eight studies which have been carried out, 
three do not use a representative sample (Kokmen et al 
1980, Sayetta et al 1985, Pfeffer et al 1987); none use 
a validated population register. One has a very low
response rate (Pfeffer et al, 1987). One does not use a 
validated screening instrument (Shibayama et al, 1986), 
and one only examines women (Brayne & Calloway 1989) and 
one only men (Pfeffer et al) and one uses very small 
numbers (Li et al 1989). The final study (O'Connor et 
al), does not use a validated population list or make full 
investigations before diagnosis. Only two studies make 
full diagnoses of the dementias (Li et al 1989 and
O'Connor et al 1989).
In summary, these studies find the commonest diagnostic 
subclassification is Alzheimer's Disease (5 studies) and 
multi-infarct dementia (3 studies). Those two diagnoses 
together accounted for between 51% and 96% of the
dementias. As expected older populations had a higher 
proportion of subjects with Alzheimer's disease, and
Alzheimer's Disease is the commonest diagnosis in the over 
65s living in the community. Although the wide variations
132
in figure suggest that there may be a true difference in 
the prevalence of Alzheimer's Disease in different 
populations, it is impossible to be certain of this 
because of varying and flawed methodologies.
7.4 CONCLUSION
A satisfactory phase II diagnostic study requires a 
satisfactory phase I study, as if the sample obtained from 
screening is unrepresentative then the phase II findings 
may be misleading. In such a study all of those who might 
be suffering from dementia from the phase I are further 
investigated. Full investigation means that a mental 
state examination, physical examination, psychometric 
tests, an informant history and laboratory investigations 
would all be obtained. The most satisfactory diagnostic 
studies are those of Folstein et al (1985), O'Connor et al 
(1989), Brayne and Calloway (1989) and Shibayama et al
(1986). These four studies all diagnose subjects found by 
screening a population in their own homes, by diagnostic 
criteria. However, as discussed above the studies are 
flawed, eg. high rates of subjects not interviewed 
(Folstein et al 1985); lack of validation of population 
lists (O'Connor et al 1989, Brayne and Calloway 1989); 
screening of women only (Brayne and Calloway 1989); and 
use of a non-validated screening instrument (Shibayama et 
al 1986). Many advances in knowledge regarding risk
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factors, prognosis, prevention and therapy for the 
dementias, require the most accurate possible 
epidemiological data. Therefore the Gospel Oak study 
described in this thesis has been carried out and is 
reported in the following chapters.
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CHAPTER 8
AIMS OF INVESTIGATIONS
The study reported in the thesis aimed to discover and 
describe the nature of dementia in a community population.
The
Aim
Aim
Aim
Aim
Aim
specific aims are stated below. Those are:
1 To set up an accurate register of all 
pensioners (women of over 60, and men over 
65) living in an inner city electoral ward 
in London.
2 To screen those people listed on the 
register using a valid and reliable semi­
structured interview to detect dementia.
3 To determine prevalence rates of dementia
within the population.
4 To determine prevalence rates of dementia
within subgroups of the population. These 
subgroups are:
a. men and women
b. those residents known to general 
practitioners and other services, and 
those residents not known to general 
practitioners and other services.
c. the age groups 65-79
70-74
75-79
80 and above.
5 To determine the rate of the diagnosis of
depression at screening in the group who 
are screened as suffering from dementia
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Aim 6
Aim 7
Aim 8
Aim 9
and compare this rate with the whole 
study.
In a Phase II study to determine 
prevalence rates of Alzheimer's disease 
and other causes of dementia in this 
community.
To discover dementias which are reversible 
and how they may best be detected in 
clinical practice.
Using psychiatrists' diagnosis as a 'gold 
standard', to analyze the usefulness of 
the instruments used in the study.
To provide further information on the 
outcome of those screened or diagnosed by 
the different methods used for predicting 
dementiaj
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CHAPTER 9
METHODS OF INVESTIGATION
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PHASE I
9-1- PHASE I - ESTABLISHING THE REGISTER
THE STUDY SITE.
The geographic area which was the basis for the sample in 
the study, was the Gospel Oak electoral ward. Gospel Oak is 
located within Hampstead Health Authority, an authority 
adjacent to central London. The ward has a population of 
6136, in some 3000 households and has high rates of most 
indices of deprivation. For example in Gospel Oak there is 
twice as much overcrowding (defined as living at more than 
one person per room), 50% more unemployment and 50% greater 
infant mortality than nationally. Eleven per cent of the 
households are headed by a person in socioeconomic group II 
(in unskilled manual occupation) as opposed to 8.7% in the 
whole of England and Wales. There is also a higher 
proportion of one parent families, still births, perinatal, 
neonatal and infant mortality (Hampstead Health Authority,
1985).
b. THE SAMPLE - PHASE I
The sample consisted of all women aged over 60 and men over 
65 who were residents of the Gospel Oak ward. An original 
list was assembled of names provided by general 
practitioners,in and around the study area, community
psychiatric nurses, district nurses and social workers. 
Addresses were checked against the electoral roll to 
increase the accuracy of the list. A small validation 
exercise then took place? all households in one part of the 
ward were visited, and names of pensioners in each house 
were ascertained. By this means this first list was 
discovered to be too inaccurate to use as a sampling frame.
It was decided to compile a second list by visiting each 
household ('door knocking') in the whole ward. The police, 
general practitioners, the hospital and the community 
services were contacted before the door knocking exercise 
began. Then the ward was 'door knocked'. All houses were 
visited, and revisited, if no reply was received at first. 
Nevertheless some houses were empty at each visit. This 
resulted in a second list, which included all residents of 
appropriate age encountered by personal contact in their 
houses. There were also some provisional entries based 
either upon information obtained from neighbours eg. 'two 
pensioners live at 94', or names remaining from the original 
list, whose presence or absence was not established at 'door 
knocking'. This second list, although still containing some 
provisional entries, became the frame from which interviews 
were arranged. It included residents of the one local 
authority residential home which was situated in the ward.
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9.2 PROCEDURE FOR INTERVIEW
At the time of 'door knocking' the Gospel Oak resident was 
asked to provide the name of his or her general 
practitioner. Although some residents were not available to 
give this information, they were often found on the lists 
originally derived from general practitioners. This meant 
that the names of most residents' general practitioner could 
be ascertained.
All general practitioners with more than three patients 
included in the sampling frame, were visited personally. 
The general practitioners were given a list of their elderly 
patient in the sampling frame and the study was explained. 
General practitioners agreed to check that their patients' 
addresses were still current, and that no-one had died since 
inclusion on the list, in order to avoid inadvertently 
sending letters to bereaved relatives. They also provided 
a supportive letter to be sent out with the letter from the 
research team requesting interview. If a general
practitioner had less than three patients in our sampling 
frame, he or she was telephoned and permission was asked to 
contact their patients. They too provided letters. We were 
unable to trace some general practitioners who had been 
named, and thus a few residents were contacted without the 
general practitioner's permission. 96% of residents were
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thus sent a General Practitioner letter and an explanatory 
letter from the hospital, together with a form to indicate 
a convenient time, and a stamped addressed envelope. If no 
reply was received, another letter was dispatched. If there 
was no response at this stage an interviewer visited on up 
to three occasions, to try to locate the person, or to 
firmly establish from neighbours whether he or she was 
living at the address.
9.3 THE INTERVIEW 
9.3a THE SHORT CARE
All subjects were interviewed on the Short Comprehensive 
Assessment and Referral Evaluation (Gurland et al. 1984). 
This is a semi-structured interview, developed from the Core 
CARE (Golden et al. 1984). Its purpose in this study was to 
detect those subjects likely to be suffering from dementia, 
depression or to be impaired in daily activity. Six 
indicator scales make up this instrument assessing organic 
brain syndrome, depression, subjective memory impairment, 
sleep disorder, somatic symptoms and activity limitation. 
The indicator scales are best regarded as screening measures 
identifying problems in these areas for further assessment. 
Two scales, those for depression and dementia, have been
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further refined to become depression and dementia diagnostic 
scales, which detect probable cases of pervasive dementia or 
pervasive depression. Pervasive dementia and pervasive 
depression are operational diagnoses which refer to 
syndromes of cognitive impairment and depressed mood, severe 
enough for further clinical intervention. These categories 
do not refer to specific conditions, disorders or subtypes 
but are meant to be useful in health services research and 
in health screening, because they identify cases where there 
is a probable need for clinical investigation or 
intervention. They are discussed in more detail below.
THE DEMENTIA AND DEPRESSION SCALES
The inter-rater reliability of the depression and dementia 
scales are 0.94, 0.76 which are estimates of the average
correlation between rater pairs (Gurland et al. 1984). They 
were gathered from data on a sample of 283 elderly community 
residents. The internal consistency coefficients for the 
depression and dementia scales are 0.75, 0.64. They are
reliable whether used by a psychiatrist or non-psychiatrist. 
A correct prediction for an elderly subject can be made for 
84% of the cases of pervasive depression and dementia and 
91% of the non-cases. The dementia diagnostic scale was 
originally validated by a one year follow-up study of
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subjects so identified, which showed outcomes consistent 
with that expected of clinical dementia in all cases. Both 
the depression diagnostic scale and the dementia diagnostic 
scales were validated against clinical judgement during a 
psychiatric investigation, which was part of a United States 
national study of hypertension in the elderly (Gurland et 
al. 1984).
The task of separating depression and dementia is attempted 
by using the depression and dementia diagnostic scales 
together. Allowance has to be made for the presence of 
cognitive impairment in those with severe depression. Lower 
levels of cognitive impairment together with higher levels 
of depression are classed as depression and conversely 
higher levels of cognitive impairment with lower levels of 
depression are classed as dementia.
ACTIVITY LIMITATION SCALE
The activity limitation scale is the third one of importance 
for this study. It too was developed from the Core CARE. 
It is scored by allocating one point to the respondent's 
report of limitation in activities of daily living such as 
going out, preparing meals, mobility and bathing. Activity 
limitation is considered present when a cut point > 7 was
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reached.
9.3b ADDITIONAL INTERVIEW ITEMS
In addition to the Short CARE, questions were asked 
concerning the following:
1) demography - name, address, date of birth, sex, 
marital status, telephone number, general practitioner, 
previous or current occupation and whether the resident 
lived alone.
2) contacts in the last month with the general
practitioner, the local hospital, the various arms of
the social services and home nursing services. Details
of visits to the home, attendances at local day centres 
or contact with local voluntary or church agencies were 
recorded.
3) details of current medication.
4) vision, hearing and mobility.
5) regular exercise and climbing stairs.
As this thesis is concerned with specific questions
regarding dementia (see Chapter 8), only those relevant 
results will be reported here.
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9.4 INTERVIEWERS
The 14 interviewers were trained in the Short CARE by 
studying and co-rating video-taped interviews. They were 
later supervised and co-rated during a live interview. Two 
psychiatrists conducted 61% of the interviews between them. 
The remaining 39% of interviews were conducted by other 
psychiatrists (35%) or psychiatric nurses (4%). All these 
interviewers were experienced in work with the elderly 
mentally ill. The field interviews took place during 1987.
Phase II
9.5 THE SAMPLE - PHASE II
All subjects living in their own home, who were cases on 
either the organic brain syndrome scale or the dementia 
diagnostic scale were reinterviewed during 1987 and 1988. 
Those who in screening were detected as suffering from 
depression, in addition to possible dementia, were still 
included in the study.
9.6 PROCEDURE FOR INTERVIEW - PHASE II
The subjects' General Practitioners were again asked to
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agree to these assessments. They sent a letter to their 
patients to this effect, enclosed with the letter from the 
research team which requested permission to visit a second 
time. The General Practitioners also acted as informants on 
past medical history. Assessment of residents always began 
with a mental state. The order of the other investigations 
depended on the subject's preference and the availability of 
the informant. All the assessments reported here, apart 
from the CT scan, were carried out in the patients' home 
some months after first screening. Full assessment took 
between two and four visits.
9.7 PSYCHIATRIC ASSESSMENT FOR DIAGNOSIS
a. CLINICAL EXAMINATION
The clinical examination consisted of 1) A mental state 
examination using the computerised diagnostic system 
GMS(A )/AGECAT (Geriatric Mental State (A), Automated 
Geriatric Examination for Computer Assisted Taxonomy) 
(Copeland et al. 1976, Copeland et al. 1986). 2) A physical
examination and biochemical tests. A sample of blood was 
taken for levels of urea and electrolytes, for liver 
function tests, including gamma glutamyl transferase, for 
blood sugar, for full blood count, ESR, B12, folate, thyroid
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function tests and syphilis serology. 3) Finally, subjects 
were asked to attend hospital for a CT Neuroscan.
b. HISTORY
The history that was taken in this study was from informants 
whom the patient was asked to nominate. It consisted of the 
History and Aetiology Schedule (HAS) (Copeland et al. 1987), 
which was developed in Liverpool to be used in conjunction 
with the GMS. Second, a detailed family history was 
obtained, to enable family lifetime risk of dementia to be 
calculated. (Chase et al. 1983). All first degree 
relatives' age at death and the causes of death were 
recorded, in addition to any cases of dementia. Third, the 
informant was also asked about the subject's occupational 
contact with aluminium and use of vibrating tools, whether 
the subject had a family history of Down's syndrome, thyroid 
diseases or lymphomas, and whether the subject had had a 
previous head injury. These exposures are all thought to be 
possible risk factors for Alzheimer's disease (Henderson 
1987, Edwardson 1988, Rocca et al. 1986). Finally, 
information concerning current medication and a medical 
history was obtained either from hospital notes or from the 
General Practitioner. Only the results from these enquiries 
which are relevant to the aims of this thesis will be 
reported.
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C. PSYCHIATRISTS' DIAGNOSTIC CRITERIA
Clinical diagnosis of Alzheimer's disease were made according 
to the NINCDS/ADRDA criteria (McKhann et al. 1984). This is 
a diagnosis based on a decrease in the patients' level of 
functioning. It defines "probable Alzheimer's Disease" as a 
dementing disorder with a typical insidious onset which 
progressively worsens over time. According to the 
NINCDS/ADRDA criteria, Alzheimer's Disease should only be 
diagnosed when there is no other systemic or brain disease 
that can account for the progressive memory loss and other 
cognitive deficits. (c.f.Chapter 3 section 4.) Definite 
Alzheimer's disease requires a histopathological 
confirmation.
The Hachinski score was calculated using informant history, 
medical history and physical examination. (Hachinski et al 
1974.) In order for a diagnosis of multi-infarct dementia to 
be made in this study, one of the following criteria had to 
be fulfilled: 1) a Hachinski score of >4, 2) evidence of
infarcts on CT Scan or 3) a history of stepwise 
deterioration. Mixed dementia was diagnosed when, in the 
presence of either of the former two criteria, the subject 
had a history consistent with Alzheimer's disease.
In the present study, to ensure all cases of Alzheimer's
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disease were identified, patients with other systemic 
disorders, such as diabetes or treated hypothyroidism, were 
not excluded from a diagnosis of probable Alzheimer's 
disease.
The data were collected by one psychiatrist (GL) and the 
clinical diagnosis checked with another (AM) so that a 
consensus was obtained.
All available information was used i.e history, GMS(A), 
physical examination, blood tests, CT scans and psychometric 
testing. However, the clinicians' diagnosis was made without 
knowledge of the results of the AGECAT classification.
9.8 PSYCHOLOGICAL ASSESSMENTS
The psychometric assessment included the following standard 
tests which will be reported here: 1) Mini Mental State
Examination (MMSE), 2) National Adult Reading Test (NART), 3) 
Kendrick Object Learning Test (KOLT) , and the 4) Word 
Generation Test or Fluency Test.
Prior to psychometric testing it was explained to carers and 
relatives that the subject required to be able to
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concentrate. In most cases the tester (KS) was therefore 
left alone with the subject.
The MMSE (Folstein et al. 1975) was included because of its 
frequent usage in dementia studies. A community version was 
used (Folstein et al. 1985) in order to removed 
institutional references from the 'Orientation' questions. 
At least two versions of the attention and calculation 
section of the MMSE have previously been used (Folstein et 
al. 1975, Brayne and Calloway 1989), with either the 'serial 
sevens' item on its own, or this item with the option to 
spell 'World' backwards. To find out if these two test 
versions were equivalent, the results of both versions were 
analyzed. The repetition phrase, 'no ifs ands or buts', was 
changed to, 'no ifs or buts'. This change was made because 
the original item was not a recognised saying amongst our 
population. (Results will be given on the number of 
subjects who might have crossed the cut-off if the more 
difficult 'no ifs ands or buts' version had been used). 
Scores out of 30 were generated in the usual way.
The NART (Nelson 1982), a brief measure of current reading 
attainment, was selected because it has been shown to be a 
good guide to premorbid functioning in populations with 
dementia. It consists of irregularly spelled words which 
the subject reads aloud. These are scored for correctness
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of pronunciation, up to a maximum 50 points.
The KOLT (Kendrick 1985) was chosen for inclusion in the 
study because it is a wide-ranging test of memory designed 
for use with the elderly. Set A stimuli were used 
throughout. The test was administered according to standard 
procedures yielding a maximum possible score of 70 points.
The Word Generation of Fluency test was based on a version 
of verbal fluency which has a long history in assessment of 
dementia and other organic conditions (Miller 1984). The 
procedure we adopted here was taken from data collected on 
elderly British samples shortly before this study started 
(Brotchie and Hart, written communication). In this study 
subjects were required to generate words from two categories 
— colours and animals - and a third category of words 
beginning with the letter M. One minute was allowed for 
each condition and the total number of words generated was 
used as the score.
9.9 RESIDENTS WHO COULD NOT BE ASSESSED
Some residents could not be assessed either because they had 
died in the period between interviews, or because they 
refused requests for reinterview. If a resident had died,
his or her notes were requested from the family practitioner 
committee. A death certificate was obtained from the 
coroner's office and any hospital notes were examined. None 
of those residents had had a neuropathological examination. 
If a resident refused reinterview the general practitioner 
and hospital notes were used to gather information. In some 
cases relatives were contacted, and they provided some 
information, in the course of ascertaining that the resident 
was not willing to be reinterviewed.
9.10 PHASE III EIGHTEEN MONTH FOLLOW UP
All residents were contacted again about eighteen months 
after first interview. They were asked to agree to 
reassessment, which consisted of Geriatric Mental State (A), 
ShortCARE, all the psychometric tests completed at first 
interview except the NART, and details of any illnesses 
since last seen. The same procedures were followed as in 
Phase II for those who were not available for interview. 
Psychiatric diagnosis was made using the information 
available. The categories improved, stable and deteriorated 
are clinical judgements made using all the raw data 
available.
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9.11 STATISTICAL ANALYSIS
a. PHASE I
The data were analyzed using the Statistical Package for the 
Social Sciences X (SPSSX) and Statistical Analysis System 
(SAS) by univariate and multivariate analysis. Univariate 
comparison used a chi-squared statistic and the 
relationships between the variables were further explored by 
logistic regression using a backward elimination method for 
variable selection. The data from the women pensioners aged 
60-64 years were excluded from analysis of prevalence rates, 
so as to provide comparable data with other epidemiological 
studies.
The cut-off point for the dementia diagnostic scale was >7 
and for the organic brain syndrome scale >4. For 
depression, the depression diagnostic scale became the basis 
of classification with a cut point of >6. Activity 
limitation was considered present when a cut point of >7 was 
reached.
A formal inter-rater reliability study was not carried out. 
However, to gain an estimate of interviewer variation, the 
prevalence rates of the three main conditions, depression, 
dementia and activity limitation were compared between the
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two major interviewers who covered 61% of the interviews 
between them. The prevalence rates of dementia, depression 
and activity limitation for the remaining 39% of interviews, 
taken as a group, were then compared with each of the two 
major interviewers. Interviews were not allocated according 
to any set pattern and, therefore, there should be no reason 
for any one interviewer to discover higher or lower rates of 
the key conditions.
b. PHASE II AND III
A. All data, except the GMS, were analyzed using the 
statistical package for the social services (SPSSx) on the 
University of London computing Centre Amdahl mainframe. 
Associations between categorical variables were assessed 
using the Chi-squared test with Yates correction where 
appropriate. Associations between the continuous variables 
were assessed using the Spearman's Rank Correlation.
B. The GMS data were scored using the GMS/AGECAT package 
(Copeland et al. 1986) in Liverpool.
C. To determine interrater reliability on the GMS, eighteen 
subjects were assessed by the two raters (GL and KS) . One 
rater observed while the other rater interviewed the
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subject. The role of each rater was randomly allocated. 
The completed interview from each rater was collapsed into 
the syndrome clusters using the AGECAT computer programme. 
The reliability of the two raters on these clusters was 
obtained using the weighted kappa statistic (Cohen 1968).
9.12 WEAKNESSES AND STRENGTHS OF STUDY DESIGN
Weaknesses of the study are that 1) A three phase study 
inevitably means attrition of numbers for interview at each 
stage. This means that by the final stage a great deal of 
information will be lost. 2) In an elderly sample many 
respondents die. It would therefore be better to complete 
an immediate detailed assessment of screen positives, rather 
than await statistical analysis of the whole sample 
interviewed. This would allow Phase II interviews to be 
undertaken immediately rather than some months after Phase 
I.
3) A control group of age and sex matched subjects who had 
not scored as cases on either the dementia diagnostic scale 
or been screened as positive on the organic brain syndrome 
scale, could have been further investigated and followed up 
in the same way as those described in the study. This would 
have increased the information available, concerning the 
specificity and sensitivity of the screening scales used.
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This was not done.
4) The design of the study means that the numbers studied 
in each phase are not be known in advance. This means 
statistical analysis may not prove possible if numbers are 
too small.
The practicalities of a dementia study in the community, 
such as the present study, means that without more financial 
and human resources, than was available to the author, so 
that very much larger populations and control groups could 
be studied, the above weaknesses are inevitable.
In contrast the strengths of this study design are:- 1) An 
accurate total population register was set up by 'door 
knocking' to use as a sample frame for the whole study. 2) 
Personal visits to those who did not reply to letters 
requesting interview, ensured a higher response rate and 
made the sample interviewed more likely to be 
representative. 3) The use of standardised, validated and 
reliable instruments in all phases of the study, meant that 
the results are interpretable and comparable with other 
studies.
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CHAPTER 10
RESULTS OF PHASE I & II
10.1 THE SAMPLE - PHASE I
The first list from those in service contact with this 
population consisted of 1,231 names. The second list 
obtained after door knocking, differed from the first by 56%, 
385 names were removed because these people were known to be 
dead or had moved, and 305 additional elderly people were 
located. The total number in the second frame was 1,151, but 
this still included some provisional entries. The accurate 
frame was eventually established after further contacts with 
residents during the approach for interviews. Another 32 
names were added, either from hearing of new arrivals in the 
neighbourhood, or discovery of someone missed by door 
knocking. Against this, 109 subjects were now discovered to 
have died, 115 had moved, 21 were too young and 6 had been 
included twice. The final accurate sample for interview 
consisted of 932 people, (women over 60, men over 65), who 
represented 15.2% of the ward population.
10.2 RESPONSE RATE
813 (87.2% of the sample) people were interviewed. 90 (9.7%) 
refused to be interviewed, 17 (1.8%) although known to be 
resident, were not found after three visits to their home, 
8 (0.85%) spoke no English and had no translator and 4
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(0.42%) were impossible to interview because they were too 
demented. These last 4 all lived in Part III accommodation.
10.3 THE SAMPLE INTERVIEWED
779 interviews were conducted in the residents' own homes, 
34 in the local Part III home. The 813 interviews were made 
up of three sub sections a) 681 living in their own homes 
who had replied to one of the two letters b) 98 also living 
at home who had not replied but agreed to an interview after 
a personal visit c) 34 residents of the Part III home. These 
three groups differed in the proportion scoring above cut 
points on the organic brain syndrome and depression 
diagnostic scales. 6.3% of responders of group (a) scored 
above the cut point on the organic brain syndrome scales (as 
opposed to the dementia diagnostic scale), whereas the rate 
was 13.3% among group (b), who had not responded to letters 
and 58.8% among group (c) , the Part III home residents. This 
was in contrast to the depression scale where 19.7% who 
answered the letters scored above the cut point on the 
depression diagnostic compared to 9.2% of those requiring 
home visits and 35.2% in Part III.
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10.4 RELIABILITY DATA
There was no statistically significant difference in 
prevalence rate of diagnoses of depression, dementia, or 
disability among the subjects interviewed by the two major 
interviewers or those interviewed by all other
interviewers.
10.5 DEMOGRAPHIC DATA
a. AGE The age range of the population studied was 
between 60 and 98 years old with a mean age of 73.8. The 
60-64 year old group of women pensioners consisted of 9.1% 
(74) of the sample interviewed. Their data have been 
excluded from other figures presented in this paper. The 
remaining sample consisted of 739 people, 34 of whom lived 
in Part III homes.
The age of the remainder 27% were between 65 and 69, 50% 
between 70 and 79 and 23% more than 80.
b. SEX 63% of the population was female and 37% male.
c. MARITAL STATUS 41% were married, 39% widowed, 5% 
divorced, 13% single and 2% separated.
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d. SOCIAL CLASS Conventional classifications of social 
class were not informative when applied to these study 
subjects, as most were retired. Forty-two per cent of women 
in the survey had worked mainly in paid domestic work, 23% 
had always been housewives, 19% had done clerical work, 9% 
had served in shops and only 7% had had professional or 
skilled work. 8% of men had previously been employed in 
professional or skilled work, 52% in semi-skilled and 40% in 
unskilled occupations.
e. LIVING ARRANGEMENTS 80% of the survey population 
living in their own homes lived in local authority housing 
and 20% were owner occupiers or rented from private 
landlords. 45% of pensioners in Gospel Oak lived alone.
f. RELIGION Most elderly in Gospel Oak were of a
Christian denomination - either Church of England (45%), 
Roman Catholic (17%), Greek Orthodox (1%) or other Christian 
denomination (8%). 23% did not state a religion. Of the
other 5% less than 1% belonged to any other single religious 
group.
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10.6 RESULTS OF SCREENING FOR DEMENTIA
a. PREVALENCE RATES
Of the 705 respondents living in their own homes, 7.9% (56) 
were screened positively on the organic brain syndrome 
scale. 5.0% (35) scored above the cut point on the dementia 
diagnostic scale and were classed, therefore, as probably 
suffering from pervasive dementia.
b. DEPRESSION & DEMENTIA
12/35 (34%) of these subjects scoring as cases on the D.D.S. 
also scored above the cut point on the depression diagnostic 
scale. This compares to 102/670 (15%) who score as
depressed but are not so classified (Chi-squared) 8.92 
p<.003 Using the formula to discriminate between diagnoses, 
10 of these 12 were then classed as suffering primarily from 
dementia. Removal of two subjects, reduced the prevalence 
rate to 4.7%. The prevalence rate, however, increased to 7% 
of the sample if the residents of the local authority home 
were included.
c. AGE AND SEX EFFECTS ON PREVALENCE
The variations in prevalence rate amongst the age and sex 
groups of the study population is shown in Table 7.
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TABLE 7
Prevalence rates amongst the age groups for males and 
females identified as cases by the dementia diagnostic 
scale.
Females (n=447) Males (n=258)
% dementia 
diagnostic 
scale
% dementia 
diagnostic 
scale
Age 65-69
n
126 0.8% Age 65-69
n
66 0. %
70-74 75 4.1% 70-74 97 1.3%
75-79 121 5.0% 75-79 62 0. %
80+ 55 12.7% 80+ 103 12.7%
The increase in prevalence rate in both sexes with age is 
clearly demonstrated. However there appears to be a marked 
difference between the sexes in the prevalence of dementia 
in the younger age bands. Standardisation of this 
population for the age distribution of the over 65's in 
England and Wales as a whole, allows an estimate of the 
prevalence rate to be 4.1%.
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Table 8 demonstrates the distribution of the diagnosis of 
pervasive dementia throughout the age groups, i.e. all those 
subjects scoring above the cut point on the dementia 
diagnostic scale.
TABLE 8
The distribution of the diagnosis of 
pervasive dementia by age
Dementia cases Non cases
Numbers 35 670
Age 65-69 3% 29%
70-79 31% 51%
80+ 66% 20%
Univariate comparisons show this diagnosis of dementia was 
closely associated with age (p < 0.001) but not sex or 
marital status.
d. THE DISTRIBUTION OF PERVASIVE DEMENTIA ACCORDING TO 
POPULATION LIST 
6/35 (17%) of those over 60 living in their own homes, were 
classified as cases on the dementia diagnostic scale but 
were not on the first list of those in contact with the 
services. This compares with 299/744 (40%) of those not
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classified as cases who were not on the original list (chi 
squared 7.45 p < 0.006). Similarly, 9/56 (16%) of those
classified as a case on the organic brain syndrome scale 
were not on the original list. But 296/723 (41%) of those 
not so classified were on the original list (chi squared 
13.49 p < 0.0002) .
10/60 (17%) of all those who crossed the cut points on
either the OBS or the DDS were not registered on the 
electoral roll.
e. PREVALENCE OF ORGANICITY ACCORDING TO RESPONSE TO 
LETTERS
6.3% of responders scored above the cut-point on the organic 
brain syndrome scales, whereas the rate was 13.3% among the 
group who had not replied to letters.
10.7 THE POPULATION DETECTED BY OBS AND DDS SCALES - PHASE 
II
35 subjects had been identified as cases on the DDS scale 
and 56 on the OBS scale. 31 were cases on both scales. 48 
(80%) of the 60 people initially identified by screening 
agreed to further assessment. As for the remaining 12 
subjects, 7 (12%) had died by the time of follow-up, 4 (7%)
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refused interview, and 1 (1%) was lost to follow up.
37 (77%) of those interviewed were female and 11 (23%) male, 
with a mean age of 80 (range 65-93). 23% were married, 17%
single, 58% widowed and 2% separated. 59% lived alone. 12% 
had never worked outside the home, 55% had unskilled 
occupations, 28% had worked in semi-skilled or skilled 
occupations and 5% were professionals.
44 (92%) lived in council houses. 34 (71%) left school at 
14. Only 2 (4%) people in the sample had 10 or more years 
of education.
10.8 PSYCHIATRIC DIAGNOSIS OF THE DEMENTIAS
Of the 48 people interviewed, twenty-two subjects (46%) were 
diagnosed as having probable Alzheimer's dementia according 
to the NINCDS/ADRDA criteria. Five (10%) were diagnosed as 
a mixed dementia, one (2%) as multi-infarct dementia, five 
(10%) as secondary dementia. Five (10%) were not suffering 
from dementia. In ten subjects (21%) dementia was not 
classified because of insufficient information. Three of 
these latter subjects provided no-one as an informant apart 
from their general practitioner. Seven others had 
informants who were unable to give any history as the 
development of memory loss. Table 9 shows the diagnoses of
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the groups detected by the DDS or the OBS scales of Short- 
CARE.
Table 9: Psychiatrists Diagnoses of Subjects Detected
by the OBS and DDS Scales of the short-CARE
OBS Scale DDS Scale Total overall
n = 56 n = 35 n = 60
no (%) no (%) no (%)
Interviewed 47 (84) 23 (66) 48 (80)
No. of deaths 4 (7) 7 (20) 7 (12)
Refused or lost to 
follow up
5 (9) 5 (14) 5 (8)
no _.(%! no m no (%)
McKhann Probable 21 (45) 12 (52) 22 (46)
Multi-Infarct 1 (2) 1 (4) 1 (2)
Mixed Dementia 5 (11) 4 (17) 5 (10)
Secondary Dementia 5 (11) 2 (9) 5 (10)
Unclassified
dementia
10 (21) 4 (17) 10 (21)
Not Demented 5 (11) 0 — 5 (10)
Total 47 (10) 23 ( 99*) 48 (99*)
* figures were rounded to the nearest whole number, the 
total is not 100%.
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Of twelve people not interviewed, four were reported, by 
either their family or their General Practitioner, to be 
suffering from dementia. Of the remaining eight people, 
seven were dead and neither hospital notes nor death 
certificates mentioned dementia. General practitioner's 
notes were requested from the Family Practitioner Committee. 
Four were located and two of these had recorded the diagnosis 
of dementia. The final subject had no general practitioner 
or other informant.
10.9 PREVALENCE RATES OF THE DEMENTIAS
From the psychiatrists' diagnoses, the prevalence rate of 
Alzheimer's disease for the whole Gospel Oak population was 
calculated as 3.1% (22/705), of multi-infarct dementia .01% 
(1/705), of mixed dementia .7% (5/705) and of secondary
dementia .7% (5/705). Therefore the overall prevalence rate 
for dementia of any type was 6.1% (43/705). If the four 
subjects reported by informants to be demented, but who were 
not assessed are included, then the total prevalence rate for 
dementia rises to 6.7% (47/705).
Table 10 shows the prevalence by age and diagnoses for each 
sex.
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10.10 REVERSIBLE DEMENTIA
No dementia was found to be reversible. The diagnoses of the 
five subjects with secondary dementia were: Parkinson's
disease (2), Korsakoff's psychosis (1), previous subarachnoid 
haemorrhages (1), and an inoperable glioma (1).
10.11 DIAGNOSTIC CRITERIA
a. GMS/AGECAT Diagnosis
The GMS(A)/AGECAT diagnosis in this study did not include the 
HAS, as a computer diagnosis incorporating history was not 
then available. The GMS(A )/AGECAT diagnosed 28 out of 48 
subjects as being organic cases, and 4 subjects as being 
subcases. An additional eight subjects had another principal 
diagnosis, but according to AGECAT, also had an organic 
syndrome. Eight subjects were rated as not suffering from 
an organic syndrome. Thus by the GMS diagnoses, the 
prevalence rate of organic caseness was 4% (28/705). If the 
12 subjects, who did not reach organic caseness are included, 
then the prevalence rate of organicity was 5.7%.
GMS diagnoses and psychiatrists' diagnoses were highly 
significantly related (p < 0.003). Six of the patients, who
171
were diagnosed by the psychiatrists as suffering from 
dementia, were not given an organic rating by the GMS/AGECAT 
system, while three other subjects who were not given a 
clinical diagnosis of dementia were classified by the GMS as 
organic subcases (Table 11).
GMS/AGECAT was more likely to diagnose as 'organic' those 
subjects whom the psychiatrists diagnosed as having 
Alzheimer's diseases (p < 0.04).
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b. RELIABILITY
Inter-rater reliability for GMS/AGECAT showed a highly 
significant agreement between the two raters on the syndrome 
cluster variables. Specifically for the organic variable the 
observed agreement was 94.4% Kappa 0.84 (p < 0.0001). For 
depression the observed agreement was also 94.4% Kappa 0.88
(p < 0.0001).
10.12 PSYCHOMETRY
Of the 48 people who were interviewed using the GMS(A) , 43 
(90%) agreed to complete the MMSE. However, only 32 (67%) 
subjects completed all the psychometric tests reported here.
NART: Results on these tests were approximately normally
distributed, with an absence of floor and ceiling effects 
except on the National Adult Reading Test. On this latter 
test three subjects scored zero and nine scored three or 
below. The mean reading attainment of this group - 11 words 
out of 50 - is considerably lower than that for the UK 
population as a whole (Nelson 1982).
MMSE: Including the alternative item - spell WORLD backwards
-in the Attention and Calculation section of the MMSE
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increased the mean group score by one and a half points (from 
17.7-19.1). This shift meant that twice as many subjects 
were classified as 'non-demented' using a cut-off of 23, when 
the alternative was included (6 v. 3 subjects). A further
two of those latter three subjects scored 24 on the MMSE I
version, but arguably might have scored 23 if the phrase 'no 
ifs and or buts' had been used instead of 'no ifs or buts'.
KOLT: The conventional cut off point for the KOLT (< 22) 
classified 23 (59%) of the sample as impaired.
WORD GENERATION: classified 27 (71%) below the cut off of < 
22.
The relationships of the various psychometric instruments 
were measured using Spearman's Rank Correlation. 34 people
completed both the NART and the MMSE. The NART scores
correlated with the scores from both versions of the MMSE 
(MMSEI .32, MMSE .42, both p <.01). There was a significant 
positive correlation between MMSE scores and KOLT (MMSEI .53, 
p < .01) and Word Fluency (MMSEI and fluency .4, fluency and 
KOLT .45, both p < .01).
The scores of patients diagnosed as probable Alzheimer's 
disease were compared to those from patients suffering from 
other types of dementia. Although differences between the
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two groups failed to reach statistical significance, the 
Alzheimer's patients obtained lower scores on all the tests.
10.13 PHYSICAL EXAMINATIONS AND BIOCHEMICAL SCREENING 
ABNORMALITIES
Two subjects had abnormal biochemical results which might 
have indicated the cause of their dementia. One subject was 
hypothyroid, despite thyroid replacement, and another subject 
suffered from B12 and folate deficiency. However, neither 
subject showed improvement, when these abnormalities were 
corrected.
10.14 HACHINSKI SCORES
Enough information was gathered for a Hachinski score to be 
calculated for 37 subjects. 32 subjects scored < 4, and five 
scored five or six. No subject scored more than six.
10.15 COMPUTERISED TOMOGRAPHIC NEUROSCANS
Eighteen (38%) subjects had CT Scans. CT Scan appearances 
are grouped according to diagnosis as shown in Table 12.
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CHAPTER 11
PHASE III EIGHTEEN MONTH FOLLOW UP
178
11.1 THE ASSESSED POPULATION
48 people were interviewed in Phase II, the diagnostic phase 
of this study (see Chapter 10). Eighteen months later 31 
(82%) of those available for interview, agreed to another 
interview and seven (18%) refused re-interview. The 
remaining ten had died.
Of those interviewed, 26 (84%) were female and 5 (16%) male. 
The mean age was 80 (range 66-95). At phase II, 13 (42%) had 
been classified as having Alzheimer's disease, 4 (13%) as 
mixed dementia, 4 (13%) as not demented, 3 (10%) as secondary 
dementia and 1 (3%) multi-infarct dementia. 6 (19%) had a 
dementia which was not classified because of lack of 
information.
The Short CARE was completed in 30 of the 31 people who were 
interviewed. GMS (A) -AGECAT was completed in 22 and 
psychometric testing in 20.
11.2 THE POPULATION - DEATHS AND REFUSALS
By follow up ten elderly people from the original 48 had 
died. Of those ten, 6 (60%) were female and 4 (40%) male. 
There is a trend towards the males being more likely to die
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than the females, but chi-squared analysis showed this not 
to be significant at the p < .05 level. The mean age at 
death was 84 (range 75-92).
At the diagnostic stage those ten individuals had been 
classified as follows - six (60%) probable Alzheimer's 
disease, two (20%) secondary dementia, one unclassified 
dementia and one was not demented. Death certificates 
recorded the major causes of death as bronchopneumonia (3), 
malignancy (3), cerebrovascular accident (1), septicaemia 
(1), peripheral vascular disease (1) and chronic obstructive 
airways disease (1).
The only reported cause of death that matched the diagnosis 
of dementia applied in Phase II, was that of a woman with a 
glioma. The patient who had died of a cerebrovascular 
accident had been diagnosed as suffering from Alzheimer's 
disease at Phase II.
Seven people refused reassessment. 5 (71%) were female, 2 
(29%) male. The mean age of this group was 80 years (range 
67-88). In phase II, 4 (57%) had been diagnosed as probable 
Alzheimer's disease, 2 (29%) as unclassified dementia and 1 
(14%) had mixed dementia.
Conclusion: 10/48 (21%) of those who were assessed in Phase
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II had died. This is twice the expected death rate in this 
age distribution (Warnes 1989). 7/48 (15%) refused
reassessment. Neither group differed significantly from the 
total group seen in Phase II.
11.3 PSYCHIATRIST'S DIAGNOSES
At follow up, 31 subjects were seen of whom 30 completed as 
least the Short CARE. The outcome of those classified as 
demented in Phase II is shown in Table 13. Those 7 subjects 
whose outcome is unknown have been excluded.
The numbers of subjects in each category, are too small to 
permit statistical analysis as to the significance of any 
differences regarding the outcome of each subclassifications 
of dementia. There was no difference between the outcome of 
Alzheimer's Disease and non-Alzheimer's Disease. Overall, 
at follow up of dementia 10 (23%) seen in Phase II were 
dead. Of the remainder 4/30 remained not demented. 14/26 
(54%) of those originally classified as demented had 
deteriorated, of whom 4 had been institutionalised. 6 (22%) 
were stable and 6 (22%) had improved. Of the 6 who had
improved, 5 still showed evidence of cognitive deterioration 
but were no longer cases, one was no longer intellectually 
impaired.
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Table 14 shows the clinical outcome of those who were crossed 
the cut point on the various instruments used in Phase II.
Conclusions: There was a trend for a worse outcome in
Alzheimer's Disease than in other dementias, but this is not 
statistically significant. The clinical improvement seen in 
people who had both crossed the cut point in the screening 
instruments, and been diagnosed as demented clinically was 
unexpected. It may be explained by a number of factors. 
Firstly, dementia may fluctuate according to physical, 
psychological or social factors, causing people to cross or 
re-cross the border of caseness. Secondly, the practice 
effect of completing many cognitive tests over a short period 
of time, will also enable some people to improve their 
performances. Finally, improvement may be due to
misclassification of acute confusional state as dementia. 
This last explanation seems least likely as subjects ewre 
impaired on both screening and further investigations some 
months apart. In addition there were no investigation 
results suggesting a secondary dementia, on physical and 
biochemical screening. The clinical diagnosis of "not 
demented" predicted failure to deteriorate. The outcomes of 
non-cases or screen negatives in the DDS, and AGECAT are 
discussed in the rest of this chapter.
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11.4 DEMENTIA DIAGNOSTIC SCALE
17/23 (74%) of those who had been cases on the dementia
diagnostic scale at first screening were reinterviewed. One 
did not complete the interview, the other 16 remained cases 
on this scale. Four (17%) people who had been cases on the 
DDS had died. Two refused re-interview. Three of the 13 
(23%) who had been cases on the organic brain syndrome scale 
and not on the dementia diagnostic scale in phase II became 
cases on the DDS.
Conclusion: In this study the DDS predicted either
continuing DDS caseness or death. However around half the 
cases did not deteriorate or improved. This contrasts with 
earlier reports (Gurland et al 1984).
11.5 ORGANIC BRAIN SYNDROME SCALE (OBS)
31 (66%) of the 47 who had crossed the cutpoint on the 
organic brain syndrome scale at the diagnostic phase were re­
interviewed, ten (21%) had died and 6 (13%) refused re­
interview.
Of the 30 who completed the interview, eight (27%) no longer 
crossed the cutpoint. Of these eight who were non-cases,
three had been diagnosed clinically as not demented but five 
were thought to be demented in the Phase II diagnostic study.
Conclusion: The OBS screening scale outcome appeared to be
similar to the other measures, despite the fact that a larger 
group crossed the cut point. This apparent similarity may 
be due to a type II error, that is a false negative because 
the small numbers interviewed in Phase III mean that there 
is a low probability of detecting a true difference.
11.6 GMS (A) /AGECAT
GMS (A) was completed for 22 subjects. Seventeen of these 
were classified by the AGECAT programme as organic. The 
remaining five were not classified as organic.
There had been nine discrepancies between GMS/AGECAT and 
clinical diagnoses at phase II (see Table 11). The first 
eight subjects were alive and had a follow up interview. The 
ninth subject had died. Eighteen months later, four of the 
six subjects AGECAT who had classified as non-organic were 
now classified as organic, the other two had no change in 
classification. The two subjects who had been classified as 
organic, while clinical diagnosis had been non-organic were 
still classified as organic. One of those subjects also
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remained a case on the OBS scale of the Short CARE. The 
other was no longer a case.
Conclusion: The outcome of GMS organicity is similar to
other measures. In this study the GMS and the DDS are less 
specific than the clinical diagnosis, as four of the GMS non- 
organic and three of the DDS non-cases changed status at 
follow up. This is in contrast to clinical diagnosis as all 
those who were clinically non-demented at Phase II remained 
so as Phase III.
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CHAPTER 12
DISCUSSION AND CONCLUSIONS
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12.1 MAJOR FINDINGS OF THE INVESTIGATIONS
The main findings of this three phase study of dementia in 
the community are:
PHASE I
1. Neither the electoral register nor General Practitioner 
and service contact lists provided an accurate total 
population register of the elderly in an inner city area.
2. The elderly population who did not respond to letters 
were more likely to be suffering from cognitive impairment 
than those who did respond; therefore prevalence surveys 
which do not include follow up of non-responders may provide 
misleading results.
PHASE II & III
3. The elderly suffering from dementia in the community 
were different in diagnostic composition to hospital samples 
which have been reported, therefore generalisation as to the 
nature of dementia from hospital studies of dementia will be 
unwise.
4. No dementias were diagnosed as being potentially
reversible in this population in phase II. Despite this in 
Phase III six cases had improved .
5. Many cases of dementia did not deteriorate over 18
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months and seven subjects improved.
6. The diagnosis of dementia predicted death in 21% and 
deterioration in 54% of the survivors whose outcome is known 
at 18 months.
7. Almost 50% of the survivors did not deteriorate.
12.2 RESULTS OF SCREENING FOR DEMENTIA IN THE COMMUNITY 
(PHASE I) METHODOLOGICAL LIMITATIONS
Despite both written and personal contact, 13% of residents 
did not take part in the interviews. Some were not 
interested because they felt they were too well to be 
considered in a survey of pensioners. Others were protected 
by their families who said that their relative was too old 
to be troubled. The response rate would probably have been 
increased, if interviewing had taken place at the same time 
as 'door knocking' and assembling the register. This 
procedure in a previous screening survey resulted in the 
highest response rate reported in the literature of 97% 
(Schoenberg et al 1985).
12.3 THE PREVALENCE RATE OF DEMENTIA
The prevalence figures were produced by an analysis of 
responses to the Short CARE. However, although the 
population interviewed was representative in terms of sex,
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of the general UK population, it was slightly older (OPCS 
1985). In the UK generally 32% of the elderly are 65-69, 50% 
70-79 and 18% over 80. Standardization of the age of the 
Gospel Oak population reduces the dementia prevalence rate 
of the dementia diagnostic scale from 5% to 4.1%.
Many factors have influenced the reported prevalence rate of 
dementia. The use of a frame established by 'door knocking', 
instead of using the electoral register, or a list provided 
of service users, affected the numbers of dementia cases. 
If the list provided of service users had not been modified, 
then a higher prevalence rate of dementia would have been 
found. This contrasts with the use of the electoral roll as 
a frame which might result in a lower prevalence rate, as 17% 
of those crossing the cut point at screening were not on the 
electoral roll (cf Chapter 10.6). This may account in part 
for the lower rate of dementia found in one study, which used 
the electoral role as the screening frame (Lindesay et al 
1989).
In addition the importance of the decision as to whether or 
not to include the local authority home for the elderly is 
emphasised. The decision alters the prevalence figures, 
reducing the dementia diagnostic scale by more than 2% (cf 
Chapter 6.3).
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Thirdly there was a marked effect of the age distribution on 
prevalence rate. Age correction in this sample reduced the 
prevalence rate of dementia by nearly 1%.
The prevalence rate of dementia using the dementia diagnostic 
scale was 4.7% of the over 65s, similar to some recent 
surveys (Copeland et al 1987 a,b). The importance of the 
assessment instrument used is reconfirmed by lower prevalence 
rate found using the Clifton Assessment Schedule (Morgan et 
al 1987). The CAPE is an instrument which is designed for 
hospital populations not for use in the community (cf Chapter
6.5). However the figures differ from another recent London 
inner city survey which used the Short CARE. In it a lower 
rate (4.6%) of dementia on the organic brain scale was found, 
despite using a lower cut point of 2/3 (Lindesay et al 1989). 
This contrasts with the Gospel Oak Study's finding of a rate 
of dementia on the OBS of 8%, using the higher cut point of 
3.4. The populations were of similar size and both were 
drawn from inner city areas of London. The lower rates found 
in Lewisham may be partially explained by the fact that the 
Lewisham sample was of a similar age group to the general 
population of England and Wales. In addition the use of the 
electoral register would be expected to yield a lower 
prevalence of dementia, possibly in the region of 20% lower 
(cf Chapter 10.6). Finally, in Lewisham forty-seven elderly 
residents were 'not contacted'. No reason is given for this,
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and they are not included in the 14% who were not 
interviewed. It is possible that those were people who did 
not answer letters sent to confirm their age and address and 
may therefore have been more likely to be cognitively
i
impaired (cf Chapter 10.3). In summary the prevalence rate 
of dementia is so influenced by the survey design, as to 
render comparisons between surveys using different 
methodology almost impossible.
12.4 SEX DIFFERENCES IN RATES OF DEMENTIA
Dementia was uncommon among the younger males in the sample. 
This sex difference reflects the similar unexplained patterns 
in many other studies (c.f. Table 4). As discussed before, 
this effect may be because men with dementia survive less 
long than women with dementia. The trends in the follow-up 
data from this study, lends some support to the explanation 
that men with dementia survive less long than women with 
dementia, as 40% of deaths were male, compared with 23% at 
outset in this sample.
It is also possible that the gender difference is an artefact 
created by the properties of the screening instruments. As 
the number of years of higher educations is inversely related 
to caseness, in at least some screening instruments for
dementia (Brayne & Calloway 1990, O'Connor et al 1989), the 
lesser education of women as a group when compared to men as 
a group, may account for this phenomenon. For example in the 
Gospel Oak Sample, 40% of men as compared to 74% of women had 
worked in unskilled occupations.
12.5 PHASE II DIAGNOSTIC COMPOSITION OF DEMENTIA IN THE 
COMMUNITY
This study demonstrates several diagnostic differences 
between the elderly with dementia, reported here and those 
that have been studied in hospitals. In the present study, 
46% were diagnosed as Alzheimer's disease, 10% a mixed 
dementia, 2% a multi-infarct dementia, 10% secondary dementia 
and 21% suffered from a dementia which was unclassifiable 
because of lack of information. This contrasts with the 
samples used in studies summarised by Clarfield (1988) (see 
Chapter 7.2). In this paper the overall rates for the common 
diagnoses were calculated; 57% of cases were due to 
Alzheimer's Disease, 13% to multi-infarct dementia, 4.5% to 
depression and 4% to alcohol abuse. Four community studies 
were quoted by Clarfield. In only one study was the sample 
found by screening (Folstein et al 1985). Folstein et al 
reported only the rates of Alzheimer's disease and multi­
infarct dementia. Recently, further studies of the
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diagnostic composition of dementia in the community have been 
published (see Table 5) (Shibayama et al 1986, Brayne & 
Calloway 1989, O'Connor et al 1989). However none of these 
studies report a full diagnostic profile of subjects detected 
as suffering from dementia by a validated screening 
instrument, and then examined in a Phase II study. Therefore 
the present study is the first to report a full diagnostic 
profile of an unselected community sample and has no complete 
data for comparison. In the present study the 21% of 
dementias, which were unable to be classified might change 
the diagnostic profile reported here considerably. However 
there is no cause to believe that those unclassified 
dementias should be of a different diagnostic composition to 
the remainder of the sample, as dementia was usually 
unclassified only because of lack of informant history. They 
may be predominantly suffering from Alzheimer's Disease, as 
the outcomes were most similar.
In this study it was striking that no subject fulfilled the 
Hachinski criteria for multi-infarct dementia (score >7). 
As there is no reason for subjects with cerebrovascular 
disease to be particularly rare in this population, this may 
reflect the fact that subjects with multi-infarct or mixed 
dementia may have neurological symptoms and signs, associated 
with physical disability, together with a more rapidly 
deteriorating mental state and behavioural problems and thus
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be more likely to be institutionalised or die. A prediction 
which follows from this is that the proportion of vascular 
dementia in comparison with Alzheimer's disease in incidence 
rates will be higher than that in the prevalence rate.
12.6 PHASE III EIGHTEEN MONTH FOLLOW-UP
Forty-three subjects had been clinically diagnosed at Phase 
II as having dementia. Eighteen months later 9 (21%) of
those had died. Of the remainder, 54% had deteriorated, 23% 
were stable and 23% had improved.
The clinical diagnosis of dementia, even in this community 
sample, with relatively early dementia was associated in the 
main, with an poor outcome. The death rate was twice that 
which is expected for the age composition of the samples 
studied (Warnes 1989), and in addition half of the survivors 
deteriorated. However this means that in contrast, nearly 
half of the survivors did not deteriorate. This may be 
because of practice effect as the same tests were 
administered several times. This has been documented in 
other studies (Teng et al 1987). Dementia may also show 
fluctuations in its course, and these may be of physical, 
social or psychological aetiology. For example physical 
illness, depression, nutrition and the receipt of formal or
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informal services may all affect the severity of impairment. 
It is possible that the present study, which was designed to 
be observational, may have influenced its own findings by 
alerting medical and other services when appropriate, and by 
administering cognitive tests many times to the same people. 
Finally subjects may have suffered from an acute confusional 
state on both screening and at Phase II interview.
The present study gives added weight to the conclusions of 
a previous longitudinal study, that the most useful way of 
improving cognition in dementia is to maximise the patient's 
health in all spheres, rather than continue the search for 
reversible dementias (Larsen et al 1984).
12.7 PREVALENCE RATES OF THE DEMENTIAS
The total prevalence rate of dementia as diagnosed by the 
psychiatrists was 6.1%, between the initial screening study 
prevalence rate of 4.7% according to the DDS and 8% according 
to the OBS. The DDS scale is probably too restrictive to 
detect all forms of the dementia syndrome. In this study, 
according to the clinical diagnoses, the prevalence rate of 
Alzheimer's disease was 3.1%. The only other comparable data 
in the over 65 age group were from Baltimore and from Nagoya, 
where the overall prevalence rate for dementia was similarly
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6.1%. (Folstein et al 1985, Shibayama et al 1986). More 
recent British studies have used different age groups thereby 
making comparisons more difficult (cf Tables 5 & 6). However 
it appears that the Cambridgeshire study finds a lower rate 
of the dementias, particularly Alzheimer's disease, than 
other studies, although only women are screened (Brayne & 
Calloway 1989). This may be because there is a lower
prevalence of dementia in rural areas as had been previously 
suggested (cf Chapter 6.3). The explanation for this
phenomenon is unknown, but possibilities include either 
different environmental exposure to risk factors, or drift
into more urban areas of those with disease. A final
possibility is that the isolation which occurs in large 
cities is a social phenomenon which may increase the 
likelihood of those who are cognitively impaired becoming 
"cases”.
It is not surprising that a higher rate of dementia was found 
in the present study, than in some other contemporary UK 
studies. Firstly, personal visits to non-responders in the 
initial screening study increased the number of cases found 
at screening. Secondly, Gospel Oak contains more very old 
people than the UK elderly population in general.
The low numbers studied meant that no statistical analysis 
could be made as to the significance of differences in
outcomes in each of the different subclassifications. There 
appears to be a trend for a worse outcome in Alzheimer's 
Disease, but this cannot be confirmed by this study. Any 
difference might be explained by the trend for those with 
Alzheimer's Disease to have a more severe dementia at outset.
12.8 REVERSIBLE DEMENTIA
In Phase II five subjects had a secondary dementia and two 
had a biochemical abnormality on blood screening, but none 
of these dementias proved reversible in practice. The total 
numbers of potentially reversible dementias seems small, so 
a case for population screening and investigation of the 
elderly in order to detect reversible dementias cannot be 
made from the data. This study again emphasises the 
differences between hospital and community. The review of 
studies by Clarfield indicated that there were 13.2% 
potentially reversible dementias, among all dementias. Yet, 
the only other study based upon a representative sample in 
the community and reporting the rates of reversible 
dementias, like the present study, did not report any 
reversible dementias (Folstein et al, 1985).
In contrast, in Phase III six subjects had improved 
cognitively, although five were still impaired. Despite no
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cause of secondary dementia being found in screening they 
proved to have a dementia which was reversible. As those 
subjects were impaired on both screening and on further 
investigation, it is unlikely that they had acute confusional 
state. A more probable explanation is the fluctuation of 
mild dementia according to physical, psychological or social 
factors.
12.9 THE DIAGNOSTIC CRITERIA
a. CLINICAL
The variation in rates of subclassifications of the dementias 
compared to other studies have been discussed in terms of 
sample bias. However, this variation may also reflect the 
use of current standard diagnostic criteria which were 
developed from work on specific clinic subjects rather than 
on a community sample. The NINCDS/ADRDA criteria, have been 
validated by post mortem examination either in samples where 
the diagnosis was made late in the illness, prior to death 
(Tierney et al. 1988), or in samples where the subjects were 
selected to have no concurrent physical illness (Morris 1988, 
Martin 1987) (cf Chapter 3.6). Community samples are likely 
to contain less advanced cases and subjects who often have 
physical illnesses. In the case of vascular dementia,
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studies reporting post-mortem validation of the Hachinski 
score found it less accurate in diagnosing multi-infarct 
dementia than other criteria (Homer et al 1988, Molsa 1985) 
(cf Chapter 3.6). Finally, on practical grounds, the 
criteria were limited in this study, for it was impossible 
to make a differential diagnosis in ten subjects because of 
insufficient information, indicating again how different 
hospital based samples are.
Clinical diagnosis of dementia was as sensitive and more 
specific than the standardised measures. It therefore 
appears that from this data using clinical diagnosis as a 
'gold standard' for validation of ante-mortem diagnosis is 
still appropriate.
b. AGECAT DIAGNOSIS
It is a new observation that AGECAT criteria for organicity 
appear to be more concordant with a clinical diagnosis of 
Alzheimer's dementia, than the secondary dementias. This may 
be because the pattern of deficit is atypical in secondary 
dementia, or because the trend was for the Alzheimer's 
Disease patients to have a more severe illness. However, the 
AGECAT diagnosis was then imperfect in that it neither took 
into account history, eg. low intelligence? nor did it allow 
for the interviewer's inability to code pathology when no
201
answer is given. For example, the question in the GMS (A) 
is not used in conjunction with other instruments. These 
problems of diagnosis are likely to be remedied as the 
History and Aetiology Schedule (HAS) can now be incorporated 
into the AGECAT diagnosis.
Other discrepancies between the GMS/AGECAT diagnoses and the 
psychiatrists' diagnoses may reflect the continuing 
difficulties in differentiating depression from early 
dementia. The 18 month follow up results suggest that, while 
psychiatric diagnosis was by no means a perfect predictor, 
the AGECAT criteria were no better than other criteria at 
predicting death or deterioration, and were less good than 
clinical diagnosis at distinguishing false and true 
negatives.
C. PSYCHOMETRY
There have been criticisms of the Mini-Mental State Exam 
(MMSE). Different versions have been created for different 
populations with differing cut-off points, so that it was not 
immediately apparent which version would be preferable for 
this study. This was investigated by scoring the MMSE in two 
ways. The results showed that inclusion of the option to 
spell 'WORLD' backwards simplified the test. Therefore, 
fewer subjects fell below the conventional cut-off of 23 on
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the easier, rather than the harder version (37 as opposed to 
40 respectively). The clustering of the community sample 
around the cut off point, suggests that it may be useful to 
use a modified MMSE, with an expanded scoring range in order 
to make finer differentiations between demented and non­
demented patients, as was done by Teng et al (1987). Another 
factor which may have influenced outcomes on the MMSE test 
scores was that the subjects were interviewed at home, and 
it is possible that this improved their scores in orientation 
questions.
Even so, the power of the MMSE to differentiate demented 
subjects was greater in this study than that of the two other 
cognitive tests used, KOLT and Word Generation. This may 
partly have been because the former is a multi-component 
test, combining information from language, attention, memory, 
literacy and drawing ability. Alternatively, the cut-offs 
on these latter tests may have been set too high. This idea 
receives support from a similar findings in a study of 164 
community residents aged over 65, which found that the 
Kendrick battery failed to detect one third of those 
diagnosed as suffering from dementia by a neurologist 
(Fillenbaum et al 1990). Despite this, the MMSE was found 
to correlate significantly with premorbid intelligence as 
measured by the NART, while KOLT and Word Generation did not. 
The latter tests may therefore be free of educational bias.
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An alternative explanation of this finding is that the NART 
is strongly related to current levels of cognitive function 
in the community dwelling elderly (Brayne & Beardsall 1990), 
this may be another indication of the usefulness of the MMSE.
d. PHYSICAL EXAMINATION AND BIOCHEMICAL TESTS
The physical examinations were of little help in the 
subclassification of dementia. This is confirmed by another 
study of patients with NINCDS/ADRDA diagnosed mild to 
moderate Alzheimer's disease, which found that although there 
were neurological abnormalities in Alzheimer's disease, they 
are too infrequent early in the course to serve as diagnostic 
markers (Palasko et al 1990). Although necessary for the 
Hachinski scores and relevant in the diagnosis of multi­
infarct dementia, this diagnosis was rare in this sample. 
Both the blood testing and the physical examination did 
uncover some abnormalities, but neither helped in diagnosis, 
nor led to any action that reversed the impairment. 
Nevertheless, subjects and their relatives were very pleased 
to have a full physical examination and investigations and 
a subjective impression was gained that these increased co­
operation with the interviewer. However the study's results 
would not justify a recommendation that every community 
patient with dementia requires physical examination and
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biochemical screens.
e. CT SCANS
Neuroimaging was the only part of this diagnostic procedure 
that took place in hospital. The co-operation of the 
subjects was markedly less either because of inconvenience, 
or fear of hospital, or because it seemed too difficult to 
come to the hospital because of physical disabilities.
The results of the CT Scans were available to be used as part 
of the diagnostic process by the psychiatrists. However only 
three diagnoses were influenced by the CT Scan results, 
namely those of the subject with a glioma and two cases where 
there was evidence of multi-infarctions, but the history was 
consistent with Alzheimer's disease. Among the remainder of 
the scans, both leuko-araiosos (white matter changes) 
(Hachinski et al 1987) and cerebral atrophy were found among 
subjects of all diagnostic categories, including those 
subjects who did not suffer from clinical dementia. These 
results indicate that while neuroimaging can be a useful 
diagnostic tool in a few subjects with an atypical history 
of dementia, in general it does not clarify diagnoses. The 
major disadvantage of its use is the distress caused to this 
population at the prospect of coming to hospital.
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12.10 SCREENING TESTS
The two scales of the Short CARE behaved differently. The 
DDS detected 35 subjects, all of those interviewed were 
deemed later to be suffering from dementia. However this 
scale missed 19 subjects with clinical dementia. The OBS 
scale detected a larger group which contained five subjects 
without dementia. Four of the DDS cases did not appear in 
the OBS group? three of these had died by the time of 
further assessment, suggesting that their loss of function 
could be associated with concurrent physical illness. 
Terminal illness is perhaps picked up by the activity of 
daily living items in the DDS which are not in the OBS scale. 
Thus, at the diagnostic stage the OBS scale appeared a more 
useful screen whereas the DDS predicted dementia or early 
death.
12.11 IMPLICATIONS FOR FURTHER RESEARCH
Despite the small numbers in this study some conclusions can 
be drawn concerning the most appropriate setting for and the 
format of assessments, which should be used with the 
community dwelling elderly suffering from dementia.
First, it is important to see people immediately after they
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have been screened. In this study seven people had died and 
were thus lost to follow up by the time contact was initiated 
some months after the first screening. Second, it is 
important to assess people at home, since many elderly people 
will be reluctant to come to hospital unless they are acutely 
ill. Third, the most important factor affecting the 
acceptability of the psychometric testing appeared not to be 
the tests themselves but the length of testing time. Though 
there was no strict testing order, the MMSE was always 
conducted first; the response rate for this test was 90%. 
The tests that were left until later were less likely to be 
completed. It seems that the shorter the testing time the 
more likely it is that more complete data will be collected. 
The diagnostic differences demonstrated between this study 
of community dwelling elderly people and studies which are 
conducted with subjects from hospitals show that it is no 
longer satisfactory to extrapolate from hospital studies in 
order to draw conclusions concerning the elderly demented 
people living in the community. As it has been almost 
exclusively the data from hospital studies, which has led to 
diagnostic criteria and subclassification of patients with 
dementia syndrome, further studies need to be conducted in 
the community, with the special needs of this population in 
mind.
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Finally, because of the small proportion of those suffering 
from dementia in the over 65s age group, and the large number 
of deaths in those suffering from dementia 17 (28%) of those 
originally screened as demented) future studies should employ 
larger and possibly older community population samples. This 
would increase the numbers of subjects, so that any 
differences which exist in outcome between the diagnostic 
subclassifications of dementia, could be found.
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